The 5 Forces Behind Almost Every Hospital Decision

One of the things I love about selling to hospitals is that it rewards people who are willing to think deeply.

This is not a market where surface-level messaging wins for long. Hospitals are complex. The people leading them are balancing financial pressure, clinical priorities, operational realities, market dynamics, and constant change. That is exactly why the sales professionals who rise to the top are the ones who learn how to see the bigger picture.

Over the years, I found myself coming back to the same pattern. There were five forces showing up again and again behind hospital decisions. Once I began organizing my thinking around those forces, it changed the quality of my conversations, the kinds of questions I asked, and the way I helped clients position their solutions.

For high-performing salespeople, this framework is incredibly useful because it helps you move from presenting a product to understanding a decision.

Force 1: Alignment to payment models

If you sell to hospitals, one of the best investments you can make is learning how the organization gets paid.

That may sound basic, but in practice it is one of the biggest differentiators. The strongest salespeople do not stop at a high-level understanding of reimbursement. They study payment models closely enough to understand what those models are encouraging hospitals to do differently.

When CMS or Medicare introduces a new model or expands an existing one, it usually shifts priorities. It can change how hospitals think about coordination, outcomes, physician alignment, post-acute strategy, cost, and risk. In other words, it shapes what becomes important.

That is why this force matters so much. When you understand the goal behind the payment model, you can position your offer in a way that feels timely and relevant. You are no longer simply describing a solution. You are showing how your solution supports success in the environment hospital leaders are already navigating.

That is a much more strategic conversation, and hospital executives can feel the difference immediately.

Force 2: Alignment to regulations

The second force is regulation. While this one can feel technical, it is often one of the clearest paths to relevance.

Hospitals operate in a highly regulated environment, and those requirements influence urgency. Whether the issue is price transparency, cybersecurity, supply chain expectations, reporting obligations, or another compliance-related pressure, regulations have a way of moving priorities to the top of the list.

For salespeople, the opportunity is not to lead with fear. The opportunity is to lead with understanding.

When you can show that you understand what a new regulation means operationally, financially, or strategically, you become more credible. If your solution can reduce burden, simplify execution, improve readiness, or help a team respond more effectively, then you are contributing something that is genuinely useful.

That is an important distinction in hospital sales. The best messages do not just describe value in abstract terms. They connect directly to what leaders are being asked to manage right now.

Force 3: Alignment to aspirations

This is the force I believe people overlook most often, and yet it is one of the most human.

Hospitals are institutions, but decisions are still made by individuals. Those individuals have goals. They have milestones they are trying to hit. They have internal expectations, incentive plans, and career ambitions. They want to make progress. They want to be seen as effective. They want to lead important work well.

I saw this clearly years ago after speaking at a hospital association event. A finance leader approached me, and as the conversation developed, it became obvious that the opportunity was not only about helping the organization. He also wanted to grow into a CFO role. If he could bring in the right partner, create meaningful results, and be known internally as someone who drove change, that mattered.

That was such an important reminder. When you understand what success looks like for the person across from you, your conversations become more thoughtful and much more effective.

You begin asking better questions. What are you responsible for this year? What are you trying to improve? What would make this initiative meaningful for you and your team? Those are the kinds of questions that create trust.

And when you help your customer succeed as a person, not just as a title, you create a deeper kind of alignment.

Force 4: Alignment to competition

Hospitals are also far more competitive than many people realize.

They are competing for patients, physicians, service-line growth, reputation, market share, and strategic position. In many markets, leadership teams are constantly thinking about how to protect their strengths, where to grow, and how to become more differentiated.

That creates a very powerful opening for the right salesperson.

If your solution can help a hospital strengthen growth, improve access, protect referrals, enhance its reputation, or become more distinctive in the market, that should be part of your story. Sometimes what looks like an operational improvement on the surface has a much bigger strategic impact underneath.

I think this is especially important for people selling into highly competitive regions. Hospital leaders are not only trying to solve problems. They are also trying to build something stronger. They are trying to lead. They are trying to win in their market.

When you understand that, your message becomes more compelling because it connects not only to operational value, but to strategic ambition.

Force 5: Alignment to unique operational pressures

The fifth force is where strong salespeople really separate themselves.

Every hospital has unique pressures shaped by its community, geography, payer mix, local market conditions, service mix, and strategic activity. One hospital may be dealing with a high Medicaid population. Another may be preparing for hurricane season. Another may be expanding services, managing staffing constraints, or addressing a recent penalty or performance issue.

This is why research matters so much.

The most effective salespeople do not stop with the website or a short company profile. They look at public information, local news, strategic developments, filings, cost reports, community trends, and other signals that help them understand what that specific organization is managing.

When you do that work, you are able to ask questions that feel relevant and informed. You show up differently. You are not talking to a generic hospital profile. You are speaking to a real organization with real priorities at a specific moment in time.

That is often where momentum begins.

Why this framework matters

What makes this framework so effective is that it helps you think more expansively about alignment.

The strongest hospital sales conversations usually touch more than one force. A solution may support a payment model, ease a regulatory burden, and help an executive deliver on a key initiative. It may strengthen market position while also solving a local operational challenge. The more clearly you can connect your offer to what the hospital is already trying to accomplish, the stronger your positioning becomes.

That is why I believe this matters so much for high performers. It gives you a way to prepare better, ask smarter questions, and create more meaningful conversations with hospital leaders.

If you want to elevate how you sell to hospitals, start here. Study the forces shaping the decision before the decision is made. Learn what leaders are navigating. Learn what they are measured on. Learn what the market is asking of them. Learn what they are trying to build.

When you do that, you do more than improve your pitch.

You become the kind of sales professional hospital leaders want in the room.

Healthcare Sales Training That Translates CMS Policy Into Hospital Deals:

Fluent in Healthcare

Most companies believe their challenge is getting in the door with hospital executives. It is not. The real challenge is what happens next.

Access without strategy leads to stalled deals, endless follow ups, and opportunities that quietly disappear. The organizations that consistently win at the executive level do something fundamentally different. They understand the market at a deeper level, they bring a clear point of view, and they know how to guide a decision, not just present a solution.

This mini-book is about how to do that.

It is a practical framework for navigating complex hospital sales, where decisions are shaped by financial pressure, regulatory demands, and competing priorities across the organization. You will learn what it actually takes to get in front of the C Suite, how to structure your first interaction so it matters, and how to build a system that keeps deals moving forward instead of stalling.

If you are selling into healthcare, this is not about selling more. It is about selling differently, at the level where the most important decisions are made.

Inside this mini-book:

What It Really Takes to Get in Front of Hospital Executives

1. Know the market better than anyone in the room

2. Stand out by bringing a point of view

3. Orchestrate the first presentation like it is your only shot

Why Your Best Deals Keep Stalling and What to Do About It

Issue 1: There is no re engagement system
Issue 2: You have optimism without a strategy
Issue 3: You are missing the organizational dynamics

How to Know Where Your Deals Stand

The 5 Step C Suite Selling System

Step 1: Get clear on what you are selling
Step 2: Connect what you sell to what is happening in the market
Step 3: Elevate your message to the executive level
Step 4: Build sales materials and train the team to use them
Step 5: Build the system to prevent stalls before they start

C Suite Selling is not easy and that is the point

Introduction

Every sales leader has had a deal that’s been “in committee” for six months.

The story likely sounds something like this.

One of my clients had a significant multi-year, seven-figure deal on the line with a major health system. The CFO had reached out because they’d identified a gap, knew they needed help, and wanted a solution. My client’s on-site demonstration went well, as did meetings with multiple stakeholder groups. By every visible measure, the deal was moving forward.

Then, it stalled.

There was no dramatic objection or competing vendor announcement, just a gradual pause.

The health system’s responses took a little longer, and the team kept extending the timeline. Updates sounded reasonable, but nothing moved closer to closing. When we finally got to the bottom of it, the reason for the stall was simple: The health system decided to conduct an internal audit of its workflows before layering in a new solution.

This was completely reasonable, but also completely outside my client’s control.

So, the deal sat still for months while that process unfolded.

Stalled deals sound like a soft “maybe,” not a hard “no.”

A stalled deal isn’t a lost opportunity, but an absence of forward motion (with a plausible-sounding reason and a timeline no one can pin down).

The updates say the deal is in review, or that the slow timeline is part of the normal internal process. But with every passing week, the executive’s priorities shift a little further, and the momentum that took months to build drains away. At companies that sell medical devices, technology, and services to major health systems, this is not an edge case.

Between 40 and 60 percent of enterprise pipelines are stalled at any given time.

So, most sales organizations have learned to absorb that as a cost of doing business rather than as a problem to be solved.

I know this because I spent two decades on both sides of it—founding, growing, and successfully exiting a healthcare consulting firm that won against billion-dollar companies. Now, I work directly with the sales organizations to close the deals I used to be on the other end of.

The stalled deal problem is not a mystery. It’s a pattern, and it’s fixable.

The reason your deals stall is that you lack consistent, repeatable access to the C-suite and a system to move them forward.

Those two problems compound each other, and the result is a pipeline full of opportunities that should be closed and aren’t.

It’s worth being direct about what’s at stake.

The financial impact is the obvious part—stalled deals are unrecognized revenue, unmet growth mandates, and missed board commitments. For PE-backed companies operating on three- to five-year hold horizons, every significant stalled deal is a direct threat to the exit multiple. For publicly held companies, the effect on shareholder accountability is real and visible.

But there’s a less quantifiable cost that matters just as much: market credibility.

Landing a major health system is a signal. Consistently failing to close the enterprise deals your team has worked to develop is also a signal. Executives at peer health systems pay attention to these signals, as do boards.

For the sales team itself, the cost is personal. High-performing reps who can’t get consistent access or can’t close the deals they work hard to develop don’t stay forever. They go to a company where the system works. The organizational damage from that (in lost relationships, institutional knowledge, and team morale) is harder to recover from than any single stalled deal.

The deals that do close at the C-suite level open a different kind of opportunity altogether.

When a healthcare company becomes a trusted partner to a health system’s executive leadership, the relationship expands in ways that transactional deals never do. They lead to co-development opportunities, long-term contracts, and relationships that make the next enterprise deal easier to close. That’s what most companies are aiming for, but the path there runs directly through the stalled deal problem.

This mini-book is about what it takes to fix both C-suite access and stalled deals.

In the pages ahead, you’ll learn:

● What it takes to earn consistent C-suite access at major health systems and why most companies are approaching it wrong

● Why your most important deals keep stalling, and the three strategic issues that are almost always behind stalled deals

● How to diagnose where each stalled deal stands before it drifts too far to recover, and the five-step C-Suite Selling System that moves deals from stalled to signed

By the end, you’ll understand how to spot, unstick, and close stalled deals. You’ll get a framework for rethinking how your organization approaches C-suite access and deal velocity, built from my direct experience selling into (and now consulting for) some of the largest health systems in the country.

Let’s begin.

What It Really Takes to Get in Front of Hospital Executives

Too many healthcare sales leaders believe C-suite access is a volume game.

Sales reps just need to do more networking, send more cold emails, and focus on follow-up. Even worse, they assume their company’s brand name will open doors on its own.

Neither works at the executive level.

Hospital Chief Financial Officers, Chief Medical Officers, and Chief Clinical Officers are navigating one of the most complex operating environments in history. New CMS (Centers for Medicare & Medicaid Services) mandates, shifting reimbursement structures, tariff pressures, and institution-specific strategic priorities mean that every vendor relationship carries higher stakes than it did five years ago.

The vendors who earn their trust aren’t the ones who show up in their inbox most often. They show up knowing what’s at stake.

That’s why the most successful healthcare sales teams consistently do three things:

1. Know the market better than anyone in the room.

A hospital CFO fielding dozens of vendor outreach attempts every week has one filter that cuts through everything:

Does this person understand my world, or are they here to explain their product to me?

Surface-level industry knowledge is enough for a conversation with a department director or a mid-level administrator. It’s not enough for the boardroom. C-suite executives think at the level of institutional strategy, financial performance, and regulatory exposure. If a sales rep can’t speak that language with credibility, the meeting ends—politely, professionally, and without a follow-up.

Two recent CMS initiatives illustrate this gap.

The Rural Health Transformation (RTH) Program and the Transforming Episode Accountability Model (TEAM) initiative are both mandates that a significant percentage of health systems must now respond to. The health systems affected are actively working through the implications. Most vendors selling into those systems don’t know them well enough to be useful in that conversation.

As a sales rep, that knowledge is your opening.

It’s not because the information is secret. (It’s publicly available on the Medicare website, in CMS presentations, and in the audio recordings of policy briefings.) The opening exists because almost no one on the vendor side does the work to stay up to date on industry-specific information.

For example, I was recently giving a sales presentation to the Chief Medical Officer of one of the largest health systems in the country. The conversation turned to a specific CMS ruling about beneficiary incentives—how hospitals can now offer patients certain incentives tied directly to outcomes without it constituting inducement. The CMO wasn’t aware of it. But I was. That single moment shifted the entire dynamic of the meeting, moving it from a vendor pitch to an advisory conversation.

That is what genuine market knowledge does at the executive level.

You become useful in a way that nobody else in the room expects.

2. Stand out by bringing a point of view.

Hospital executives hear the same claims from dozens of vendors every month.

“We can help you save money, reduce risk, and improve outcomes!”

The language is nearly identical across companies, categories, and pitches. The vendors who get remembered (and called back) arrive with a unique perspective on the problem. This isn’t product claims repackaged as insights, but a genuine point of view:

● An insight the executive hasn’t considered

● A framing of a problem that changes the conversation

● A truth about their organization that they haven’t been able to see

Here’s an example of what this looks like in practice. In the purchased services category—vendor contracts and outsourced services—there’s a fundamental visibility problem that most hospital finance teams don’t know they have. Enterprise Resource Planning (ERP) systems capture what was paid. They don’t capture what was inside the invoice. With purchased services, there’s no purchase order line, SKU, or receiving record. Every rate, every unit count, every billed quantity lives inside the invoice document and nowhere else.

Finance only sees a total, and that total gets processed and paid.

Most healthcare CFOs are accountants by training who care deeply about the details. But they have no idea this visibility issue exists. Neither do their consultants and vendors, who work with the same aggregated spend data, like contract benchmarking and category comparisons. All of it relies on totals, instead of the actual line items where potential savings live.

You can’t save what you can’t see.

Almost nobody sees this issue. But this one POV—you can’t save what you can’t see—has opened more C-suite conversations than any amount of outreach or follow-up could have for my clients and me. Especially when delivered clearly, backed by specifics, and offered without hedging.

A point of view like that doesn’t come from a positioning exercise or a messaging workshop.

It comes from genuinely knowing the customer’s world and being willing to put in the hard work to root out the problem and design a different solution.

3. Orchestrate the first presentation like it’s your only shot.

The first sales presentation is where your deal either converts into a relationship or ends.

I’m a strong believer that this is the most underestimated moment in the entire sales process. Most companies treat it like a formality. Those who close enterprise deals treat it as a strategic asset.

Unfortunately, most first presentations go something like this: There are 10 people on the call, and the first 20 minutes are spent on company history (the founding story, team bios, and headcount). By the time the reason for the meeting surfaces, the executive has mentally checked out.

You earn or lose a room in the first 90 seconds.

C-suite leaders don’t wait for the second half of a deck to decide if a conversation is worth their time. They make that call almost immediately. And most presentations give them every reason to move on.

To earn the room, lead with the big idea.

Share the specific insight you uncovered, the problem that matters right now, or the thing that makes the executive lean forward.

Instead of saying “let me tell you about our company,” say “here’s what we’ve seen across health systems like yours, and here’s why it matters right now.” Give concrete examples, specific numbers, and actual situations over hypotheticals.

Here’s what that looks like in practice:

● With clients, I’ll often open with something like: “You’re evaluating implants on cost per case, but the real value is whether they enable procedures you’re not doing today.”

● Or: “You’ve invested in automation, but your teams are still doing manual work because the data isn’t connected where decisions are made.”

Neither of those is a product claim, but both changed the conversation immediately.

The executives I’ve most respected have done the same thing at scale.

Glen Tullman built Livongo on a single reframe: people with diabetes don’t want to be more engaged with their disease—they want to spend less time on it. That one line challenged the chronic disease management industry’s core assumption before he ever mentioned a product.

Gary Guthart, the CEO of Intuitive Surgical, never pitched the da Vinci system as a robot. His reframe was that the story wasn’t the cost of the equipment. It was the total cost of patient care, and how a well-run robotics program is often the most profitable thing a hospital runs. That shift, from capital expense to financial outcome, is what turned a $1.5 million piece of equipment into a C-suite conversation.

A reframe makes the executive see their situation differently and earns the room.

But earning the room is only half the job. The close of that first sales presentation matters just as much as the open.

● A team that ends with “let us know if you have any questions” has handed control of the relationship back to the buyer.

● A team that ends with a specific, low-friction request—”If you can share this particular data set, we’ll run an analysis and send you back your own numbers with our findings within two weeks”—has done something fundamentally different.

A request gives the executive a reason to stay engaged. So the next step is your responsibility, not the executive’s. Asking for something instead of waiting for something is often the difference between a deal that moves forward and one that stalls.

Getting C-suite access is step one.

Having consistent C-suite access is hard, and many sales teams never achieve it reliably.

But another important aspect of C-suite selling that often gets overlooked is that the quality of your pre-presentation work affects what happens after the meeting.

Companies that invest in deep market knowledge, a differentiated point of view, and a strong first presentation tend to see fewer stalled deals. When deals do stall, they recover faster because the executive already sees them as a trusted voice. This means re-engagement is a continuation of a relationship rather than a cold restart.

That said, deals can still stall when C-suite access is done well.

The executive goes quiet, and follow-up emails go unanswered. The pipeline update sounds the same as last week. A lot of sales organizations don’t have a clear explanation for why or a system for what to do about it.

Let’s fix that.

Why Your Best Deals Keep Stalling, and What to Do About It

A stalled deal rarely announces itself.

It tends to dissolve slowly, with each update sounding vaguely reasonable:

“It’s still in review.”

“We’re waiting on the committee.”

“They’re just slow. It’s a long sales cycle.”

All of these excuses normalize stalled deals. They’re accounted for in forecasts, explained away in pipeline reviews, and treated as an inevitable part of selling into large healthcare systems. The team rationalizes the situation enough that action feels premature.

By the time you recognize a deal as truly stalled, you’ve already lost meaningful leverage.

After working with healthcare sales organizations for decades, I’ve seen the same issues repeatedly stall deals. They’re not always apparent, and they’re rarely named directly. But they’re often misdiagnosed as timing problems, when they’re almost always strategy problems.

Here are the most common issues that lead to stalled deals:

Issue #1: There’s no re-engagement system.

Most re-engagement is an email: “Just wanted to see if there were any updates on your end.”

That kind of outreach creates no urgency and adds no value to the executive’s world. What unsticks a stalled deal is a specific, relevant reason that gives the executive cause to move forward.

I’m a big believer that the best re-engagement strategy isn’t reactive.

It starts during the first presentation, before a deal has any chance to stall.

As the meeting comes to a close, give a simple request: Send us one specific data set, and we’ll run an analysis and come back with our findings. This should be something the team can easily pull, like a canned report. You don’t want to make it too labor-intensive.

If a deal stalls, an early data exchange becomes the re-entry point.

An executive who went quiet three months ago will read an email that says, “Based on the preliminary analysis we ran on your data, we’ve identified $1.5 million in opportunity. This is a first pass. Once we begin the engagement, we expect it to be significantly more. Would you like to reconnect next week?”

Speculative claims from a vendor are easy to ignore. But you can’t argue with your own data.

A specific finding based on the hospital’s own numbers is invaluable for moving a deal forward.

Other re-engagement tools that work are thought leadership tied directly to a regulatory or competitive shift the executive is actively navigating, peer benchmarking that shows how comparable health systems have addressed the same challenge, and a well-timed prompt that reconnects the executive’s personal strategic goals to what your solution delivers.

Issue #2: You have optimism without a strategy.

Sales cultures are optimistic by nature.

That’s not a criticism—optimism is part of what makes a high-performing team function. But unchecked optimism about stalled deals is expensive. When the team believes a deal is still alive because the executive hasn’t said no, risks go unaddressed. Competitive activity goes unmonitored. The executive’s shifting internal priorities (budget cycles, leadership changes, or new initiatives that have displaced yours) don’t get surfaced in time to respond.

One of the most valuable shifts a sales organization can make is learning to ask:

What could go wrong here?

This is a proactive discipline, not a reason to catastrophize. If you know the risks, you can address them before they become deal-killers. If you don’t, you find out when it’s too late to do anything about it.

To do this, ask strong questions in every executive interaction.

Don’t ask: “How are things going?” Instead, ask: “What’s changed in your priorities over the last 60 days?” Not “are we still on track?” but “is there anything that could slow down the decision on your end?”

To do this well, you have to pay close attention to the competitive landscape. Because in healthcare, a vendor that’s moving while you’re waiting is the one that wins.

Issue #3: You’re missing the organizational dynamics.

Deals at the C-suite level stall because the buying environment inside a health system is genuinely complex.

There are:

● Committee structures that move slowly

● Multiple decision-makers with competing priorities

● Internal champions who may want the deal to happen but don’t have the organizational influence to push it forward on their own

To work through this, ask: Does our internal champion have what they need to advocate for this deal when we’re not in the room?

A healthcare executive who was enthusiastic in your presentation still has to sell the decision internally to peers, the board, and budget owners. If they don’t have a clear, concise way to explain the value (or if the ROI case isn’t defensible under scrutiny), the deal stalls in committee. It’s not because the executive changed their mind, but because they ran out of ways to communicate your value.

This is exactly what happened with the client I mentioned at the start of this book.

The deal had been progressing well—they gave a strong on-site demonstration, had productive meetings with multiple stakeholder groups, and got genuine executive interest. Then, the health system decided to conduct a thorough internal audit of its own workflows. It was the right decision for them, but it meant months of internal work they had to build from scratch.

So, our response was to offer something they could actually use.

We’ve reached out and said:

“As you’re auditing your own process, would you like to see how other hospitals have done the same? We definitely have a process and a framework that hospitals have used. Would this be helpful?”

Right away, they answered, “It would absolutely be helpful.”

They were essentially building the audit from scratch. My guess is that it was tough to even start the audit because they had to map it out. So this gave them a framework for how others have done it. It was in a really nice, very well-designed, very well-written document. They used it and absolutely loved it.

Most importantly, it helped them complete their audit and continue with my client in the process.

Soon, the stalled deal was unstuck.

The principle is the same one that runs through every effective re-engagement strategy: Be useful in a way no one else is. Don’t do this in a generic “we’re here if you need us” sense, but be specifically useful in the context of what the executive is working on (and worried about) right now.

How to Know Where Your Deals Stand

Not all stalled deals are the same.

Treating them as if they are is one of the most common and costly mistakes a sales organization can make. Understanding where a deal sits on the spectrum determines what you can still do about it. A useful way to think about this is a simple traffic light framework:

● Green zone: The deal is paused but warm. The executive is still reachable, the relationship is intact, and proactive re-engagement can accelerate it. These are your highest-leverage opportunities, and they should be treated as such.

● Yellow zone: The decision timeline is slipping. The risk of reprioritization or competitive entry is real. The window for easy recovery is closing, and what’s needed is a targeted re-engagement strategy—not another check-in.

● Red zone: The deal has stalled long enough that competition has entered, executive focus has shifted, and margin concessions start to look tempting. Recovery is difficult and expensive. Sometimes, the right answer is a graceful exit rather than a desperate push.

The traffic light framework is simple to use, but it requires an honest assessment that optimistic sales cultures aren’t always wired to do on their own. Most companies don’t have a system to diagnose which “zone” their deal is in. This means they apply the same tactics to a red-zone deal as a green one, and then wonder why nothing moves.

A simple starting point is to pull every deal in your pipeline that hasn’t moved in the past 30 days or more, assign each one a zone, and then look for patterns. Most sales leaders find the distribution more concerning than they expected. That’s often the moment when the stalled-deal problem stops feeling abstract.

Once you know where your deals get stuck, you can begin building the system to fix it.

The 5 Step C-Suite Selling System

The following five steps are as much a thought exercise as a framework.

As you work through them, keep your own company in mind. Notice when the answers come easily and when they don’t. These gaps often lead to stalled deals.

This is the process I developed over two decades of selling into health systems myself, and the same process I now use with clients to help them build consistent C-suite access and close the deals that matter.

The goal is to help you see your own commercial situation through a different lens.

Step 1: Get clear on what you’re selling.

Before messaging, deck design, or access strategy, you need a deep understanding of what you sell, where it fits in a health system’s world, and what problem it solves at the executive level.

This sounds obvious, yet it’s almost never clear.

A lot of companies can describe their products. Very few can articulate how it connects to the strategic priorities of a CFO, a CMO, or a Chief Clinical Officer. And fewer still can map it to what that specific executive is personally accountable for this year. There’s a significant difference between the two, and that difference determines whether you’re having a supply chain conversation or a C-suite conversation.

A spine company I worked with is a good example. They had been stuck selling to supply chain for years and had solid relationships at the department level, but no traction at the executive table. When we dug into what their product did, something different emerged: the technology enabled access to a net-new surgical population, patients who previously weren’t candidates for surgery at all.

That’s not a cost reduction story. That’s a top-line revenue story, and it’s a conversation for a CFO who has to report growth to the board. The product hadn’t changed, just the understanding of where it fit.

The questions to ask your own team:

● What is our flagship offering, and what is its highest-value application in a health system context?

● Who does it impact beyond the department that uses it directly (supply chain, reimbursement, operations, patient outcomes)?

● What does a health system executive have to believe to say yes, and do we have a clear path to helping them get there?

The companies that can answer these questions are the ones getting in front of the executive who can say yes.

Step 2: Connect what you sell to what’s happening in the market.

Once you understand your product in depth, the next step is to connect it to the external environment—the regulatory shifts, competitive pressures, and institutional priorities that shape executives’ decision-making right now.

Most companies do a version of this for their marketing materials.

That’s not what this step is about.

This is about your reps knowing the market well enough to teach it, not just to mention it. They have to walk into a CFO’s office and surface something the executive hasn’t seen or thought of yet. This requires staying on top of insights and industry trends.

Most companies won’t do deep industry research, which is exactly how you stand out.

For example, I discovered the TEAM Initiative—a significant CMS mandate—through a client engagement. I was working with a company that had a cardiac surgery product, doing a deep dive into everything their product touched. Through that research, I came across the TEAM program before most people in the market were talking about it. That knowledge became a differentiator not just in one meeting, but across multiple engagements where executives hadn’t yet mapped the mandate to their own operations.

That’s the level of market depth this step requires. It typically takes three to four weeks of focused research to build properly. In my experience, the companies that invest in this work show up to C-suite conversations with information nobody else is bringing. That changes the dynamic before you’ve said a word about your product.

You can ask these questions to pressure-test:

● What CMS or regulatory changes are directly relevant to what you sell, and do your reps know them well enough to explain the implications — not just name them?

● What is the competitive landscape inside the health systems you’re targeting, and are your real differentiators built into how the team sells or just into the product brochure?

● What are the specific strategic priorities of the systems on your target list, and how much of that is publicly available in annual reports, board presentations, or leadership interviews?

When you or your reps know something the executive doesn’t, the entire dynamic of the conversation shifts in your favor before you’ve said a word about your product.

Step 3: Elevate your message to the executive level.

Armed with product depth and market intelligence, the third step is translating that into a message that resonates specifically with C-suite leaders.

C-suite executives think in terms of strategic priorities, financial performance, competitive positioning, and institutional reputation. They are not looking for a product demonstration. They are looking for a perspective that helps them see their own situation more clearly, and a credible path to the outcomes they’re accountable for.

I’m a big believer in writing thought leadership directed at what a hospital CFO or CMO needs to know.

Don’t share generic industry content. Give a specific perspective on the decisions that are live for executives in that role right now. Directors and VPs below the C-suite will read it too, because they want to anticipate what their leadership cares about. You never lose by writing to the executive level. You always lose by writing below it.

The questions to work through:

● What are your genuine points of view that executives would find useful or surprising?

● What does a peer health system leader already know, and what can you tell them that they don’t? The gap between those two is where the conversation gets interesting.

● Does your message speak to the specific executive you’re meeting with (their role, accountabilities, and current strategic context), or is it the same message regardless of who’s in the room?

Step 4: Build sales materials and train the team to use them.

Strategy and messaging are only valuable if they translate into materials the sales team can use. This is where many organizations lose the work they’ve done in the first three steps.

There are two common failure modes.

The first is creating generic materials that can’t be customized to a specific health system or executive. The second is creating excellent materials and then failing to train the team on how to use them. So reps fall back on the familiar generic deck that wasn’t working in the first place.

Here’s what a well-built set of materials looks like in practice:

● A first presentation designed to open with the big idea and the executive’s priorities

● A follow-up sequence built to prevent stalls, including a specific data request that keeps momentum in the team’s court

● Custom data assets built around a specific health system’s own numbers, gaps, opportunities, and situation

● A train-the-trainer model: one internal expert who understands the strategy deeply enough to coach the broader team

Remember, the market is constantly changing. So you have to stay up to date on new mandates, competitive shifts, and executive priorities. The best engagements include a mechanism for keeping the materials current rather than treating them as a finished product.

Step 5: Build the system to prevent stalls before they start.

The most valuable work happens before a deal gets the chance to stall.

Companies that consistently close at the enterprise level build an orchestration system around every active deal. Consider this a relationship-management and re-engagement protocol that keeps the executive engaged while always keeping the ball in your team’s court.

This is where the bake-off strategy becomes relevant.

When I ran VIE Healthcare, I once competed against much larger firms for a significant five-year contract with a well-known health system. All three companies under consideration provided similar services, and the health system struggled to differentiate among them on paper. Instead of waiting for them to figure it out, I suggested a bake-off.

Give all three of us the same, small pilot project and see the work in real time.

I knew my competitors couldn’t move as fast as we could. We completed a thorough analysis with detailed findings in two weeks, while the other firms dragged it out. The health system didn’t need to rely on promises or presentations to make the decision. They’d seen the work.

We won the five-year contract.

Two years later, a different health system found itself in the same situation. I offered the same suggestion, and we got the same outcome.

The principle behind the bake-off is the same one behind the data request after the first presentation. Don’t wait for the buyer to figure it out. Give them a reason to move, and make that reason concrete.

The questions every deal team should be able to answer:

● What happens after the first meeting? What specific ask does the team make that keeps the next step on their plate rather than the buyer’s?

● What are the early warning signs that a deal is moving from the green to the yellow zone, and what’s the response plan when that happens?

● Does each executive in the buying process have what they need to advocate for the deal internally? What would make that easier for them?

Now, you can’t prevent every stalled deal. In a complex buying environment, some deals will stall regardless. The goal is to reduce them significantly, catch them early when they do occur, and never let a green-zone deal drift to red because no one was paying attention.

C-Suite Selling Is Not Easy, And That’s The Point

“This is not easy” is one of the first things I say to clients before we begin working together.

Selling to the C-suite at major health systems is among the most demanding tasks a healthcare sales organization can undertake. It requires a depth of market knowledge most teams haven’t built, a precision of message most pitches don’t achieve, and a level of orchestration—across access, positioning, first presentation, and post-meeting follow-through—that very few organizations have turned into a repeatable system.

That’s not a criticism of the people doing the work.

The sales leaders and commercial officers I work with are talented, motivated, and deeply committed to growing their companies. The problem isn’t effort. It’s that nobody handed them a system that works at this level, and building one from scratch while managing a pipeline, a team, and a board is genuinely hard.

But over two decades, I’ve consistently seen the companies that build this system close different deals. They get longer contracts, stronger partnerships, and relationships with health system executives that expand over time. Those companies stop competing on price because they’re no longer being evaluated the same way as everyone else.

The ones that don’t build the system keep absorbing stalled deals as a cost of doing business—until the missed growth mandates, the lost talent, or the pressure from a board or a PE timeline makes that no longer an option.

The path from where most companies are to where they want to be is not a mystery.

It’s a system, and it’s buildable.

The companies that create a C-suite selling system become the vendor that health system executives call when something important needs to get done.

If you recognize your company in any of these pages, the next step is a conversation.

I work with mid-market and enterprise healthcare companies to build the strategy, messaging, and systems that unlock C-suite access and close the deals that matter. My engagements are customized, intensive, and built around the specific commercial challenges of your organization.

To learn more, visit –

Lisa's website

Healthcare Sales Masterclass Training

Fluent In Healthcare Training

About Lisa T. Miller, MHA

Lisa T. Miller is a healthcare strategist, commercialization advisor, and former CEO of VIE Healthcare Consulting, a firm she founded in 1999 and grew into one of the Top 10 healthcare consulting firms in the United States. In 2022, VIE was acquired by Morgan Stanley Capital Partners.

Over a 30+ year career, Lisa has built a reputation for closing complex, high-value deals with hospital executives and helping organizations improve financial performance, operational efficiency, and patient outcomes. She developed a proven C-Suite selling framework that combines deep industry knowledge, education-based selling, and precise value articulation—enabling companies to access senior decision makers and secure multi-million-dollar engagements.

Lisa’s work is grounded in a rare dual perspective. She has spent decades inside hospitals advising CEOs, CFOs, COOs, and service line leaders on critical operational and financial decisions, while also building and scaling a national consulting firm that competed successfully against much larger organizations. This gives her a clear understanding of how healthcare organizations function—how decisions are made, where initiatives stall, and what drives action at the executive level.

In addition to her advisory work, Lisa has developed innovative technologies, including her patented Invoice ROI™ system, designed to uncover financial opportunities within complex healthcare spend. She was the host of “The Healthcare Leadership Experience” podcast, recognized as a top healthcare podcast by Feedspot, where she shares insights on margin improvement, operational strategy, and growth.

Today, Lisa advises healthcare organizations and companies that sell into healthcare on strategy, growth, and commercialization. Her focus is on helping leaders translate complexity into clear decisions, align solutions with what health systems value, and pursue opportunities that drive measurable impact.

She is the host of the podcast Selling to Healthcare and publishes a Substack Selling to Hospitals, where she shares insights on C-Suite selling, healthcare economics, and how companies can align with what health systems value.

There is a document published every year that tells you exactly what every hospital in your target market is being financially pressured about, which executives own those pressure points, and what the cost of inaction is — down to the dollar.

Most sales teams have never read it.

It is the annual CMS rulemaking cycle — the Federal Register updates, final rules, and program announcements through which the Centers for Medicare and Medicaid Services communicates the regulatory and financial environment that governs hospital operations. It is publicly available. It is free. And it contains more actionable intelligence about your hospital accounts than any market research report you will ever pay for.

The fluent seller reads it the way a financial analyst reads an earnings release — not for compliance purposes, not out of academic interest, but to identify where the pressure is building, which organizations are most exposed, and what the commercial opportunity looks like before the rest of the market figures it out.

The companies that have built this habit into their go-to-market motion do not chase deals. They position themselves ahead of the pressure and let the market come to them.

Here is the map.

Program One: HRRP — The Penalty That Never Goes Away.

The Hospital Readmissions Reduction Program has been penalizing hospitals since 2012, and it remains one of the most commercially significant CMS programs for companies selling into health systems — not because it is the largest program, but because it is the most visible, the most consistently discussed at the leadership level, and the one most directly tied to identifiable clinical and operational failures that vendors can credibly claim to address.

The mechanics are straightforward. CMS measures readmission rates for specific conditions — heart failure, heart attack, pneumonia, COPD, hip and knee replacement, coronary artery bypass grafting — and compares each hospital’s performance to a national benchmark adjusted for its patient population. Hospitals with excess readmissions receive a payment reduction on all Medicare discharges — not just the ones driving the readmissions, all of them — up to a maximum of three percent.

In a health system receiving $200 million in annual Medicare reimbursement, a three percent penalty is $6 million. That is not a line item. That is a strategic problem.

More than $550 million in penalties is distributed annually through this program. Roughly half of all hospitals in the country receive some penalty in any given year. The hospitals in the highest penalty tier are not obscure safety-net facilities — they are large, well-resourced regional systems with sophisticated leadership teams who are acutely aware of their readmission performance and actively looking for solutions.

What the fluent seller knows that the average rep does not: CMS publishes each hospital’s readmission rates and penalty status publicly every year. You can identify, before you ever make a call, exactly which of your target accounts are in the penalty tier, which conditions are driving their exposure, and how their performance compares to peer institutions. That is your opening. That is your reason for the call. That is the conversation that gets the meeting.

Program Two: VBP — The Two Percent That Focuses Every CFO’s Attention.

The Hospital Value-Based Purchasing program does something elegant and consequential. It takes two percent of every participating hospital’s Medicare reimbursement — withheld upfront — and redistributes it based on performance across four domains: clinical outcomes, safety, efficiency and cost reduction, and patient and caregiver experience.

Hospitals that perform above the national median get their two percent back plus a bonus funded by the penalties collected from underperformers. Hospitals that perform below the median get back less than they put in. The spread between the best and worst performers in a large health system can represent tens of millions of dollars annually.

This creates a very specific dynamic for sellers. Every hospital executive is aware of their VBP score. The CFO tracks it because it directly affects net reimbursement. The CMO owns the clinical outcomes domain. The CNO owns the patient experience scores, which carry significant weight in the program. The quality team owns the safety metrics. And the CFO wants all of them to own their numbers, because the aggregate performance determines whether the hospital is a net receiver or a net payer in the redistribution.

If your solution improves clinical outcomes, reduces preventable harm events, or drives better patient experience scores, you have a direct line into this program. The fluent seller does not just say their solution improves quality. They say it in the specific language of the VBP domain it addresses, with reference to how the scoring methodology works and what a meaningful improvement in that domain is worth in recovered reimbursement. That is a different pitch entirely.

Program Three: TEAM — The Bundled Payment Mandate That Is Reshaping Surgical Sales.

The Transforming Episode Accountability Model is the most consequential CMS development for companies selling into surgical service lines in the current environment, and it is still underappreciated by the majority of sales teams operating in that space.

Here is what TEAM does. For hospitals selected to participate — and participation is mandatory, not voluntary — CMS bundles the payment for an entire surgical episode into a single target price. The episode begins at admission and extends ninety days post-discharge. If the hospital’s actual costs across that entire episode come in below the target price, they keep the difference. If they exceed the target, they pay back the overage.

The implications for purchasing decisions are significant. Under a traditional fee-for-service model, a hospital is mostly accountable for what happens during the inpatient stay. Under TEAM, they are accountable for everything that happens in the ninety days after the patient leaves — readmissions, skilled nursing facility stays, home health utilization, outpatient visits, complications that require additional intervention. The entire post-acute cost picture is now the hospital’s financial responsibility.

This changes the conversation around surgical technology, care coordination, patient monitoring, post-discharge engagement, and every other category that touches the surgical patient journey. Products and services that could previously be evaluated on their standalone clinical merits are now being evaluated on their contribution to episode cost and outcome — a broader, more financially sophisticated frame.

The company that walks into a surgical service line conversation knowing the hospital’s current TEAM performance data, understanding which episode types are creating the most cost variance, and articulating how their solution affects the ninety-day cost picture is in a categorically different conversation than the one leading with clinical features. That is the TEAM opportunity. It is open right now and most of your competitors are not yet speaking the language.

Program Four: ACCESS — The Ten-Year Wave Most Sellers Are Missing.

The Achieving Comprehensive Care for Existing Serious Symptoms program — ACCESS — is a chronic care model that covers approximately two-thirds of the Medicare population and is designed to transform how hospitals and health systems manage patients with complex, ongoing conditions over a ten-year horizon.

The commercial relevance of ACCESS is different from the penalty-driven urgency of HRRP or the bundled payment accountability of TEAM. ACCESS creates a long-horizon investment thesis. Health systems that are serious about performing well under this model are making structural changes to how they identify, engage, and manage high-risk patients across their entire population — changes that require technology, care management infrastructure, data analytics capability, and clinical workflow redesign.

For companies selling care management platforms, patient engagement tools, analytics solutions, or chronic disease management programs, ACCESS is not a single sales conversation. It is a market-shaping event. The health systems that take it seriously are not looking for a vendor. They are looking for a partner capable of thinking across a ten-year performance horizon.

The fluent seller understands that ACCESS conversations happen at a different altitude than HRRP conversations. They are not about avoiding a penalty this year. They are about building a care delivery capability that performs under a model that will govern two-thirds of Medicare reimbursement for the next decade. That is a board-level conversation. It is a CEO conversation. It is the kind of conversation that does not happen unless the seller demonstrates they understand the model at the depth required to be credible at that level.

Program Five: Rural Health Transformation — The $50 Billion Market Most Sellers Have Not Found Yet.

Rural hospitals operate in a different financial and regulatory universe than their urban and suburban counterparts. Lower patient volumes, higher rates of uninsured and Medicaid patients, older physical infrastructure, persistent workforce shortages, and thin or negative operating margins characterize much of rural healthcare in the United States. CMS has recognized that the standard payment models designed for high-volume urban health systems do not work for rural providers, and it has responded with a $50 billion investment in rural health transformation that is reshaping what rural hospitals can access, afford, and prioritize.

The Rural Emergency Hospital designation, value-based payment models adapted for rural providers, and targeted investment programs for critical access hospitals create a wave of purchasing activity in a market segment that most healthcare sales organizations have systematically underinvested in — because the per-deal size looked smaller and the sales motion looked harder.

Both of those assumptions are wrong. Rural health systems are making purchasing decisions right now, backed by federal investment, in categories where the competitive landscape is far less crowded than in urban markets. The sellers who understand the specific rural health regulatory environment — who can speak to critical access hospital financing, the Rural Emergency Hospital model, and the specific CMS programs designed for this market — are finding that their fluency creates an almost immediate competitive advantage in accounts where most vendors have never shown up prepared to speak the language of the room.

Program Six: IOTA — The Upside Most Transplant Programs Do Not Know They Are Leaving.

The Increasing Organ Transplant Access model creates financial incentives for kidney transplant centers that expand access, improve outcomes, and reduce waitlist mortality. Participating centers that hit performance targets can receive up to $15,000 per case in upside payments — a significant number for programs performing hundreds of transplants annually.

IOTA is a narrower program than the others in terms of the hospital population it affects, but for companies selling into transplant programs — surgical devices, immunosuppression management platforms, post-transplant monitoring solutions, organ procurement technology — it is the most directly relevant regulatory context for every conversation with a transplant program director, medical director, or CFO overseeing the transplant service line.

The fluent seller in this space does not walk in and talk about improving transplant outcomes in the abstract. They walk in and talk about IOTA performance targets, the specific metrics that drive upside payments, and how their solution moves the needle on those metrics in ways that are measurable and documentable. That is a conversation about revenue. That is a conversation that gets immediate executive attention.

How to read a CMS update like a sales intelligence report.

Every time CMS publishes a new rule, proposed rule, or program update, there is a standard set of questions a fluent seller asks.

Which hospitals are affected, and which of my target accounts are in that group? What is the financial exposure — what does a hospital at the median level of performance stand to lose or gain? Which executive inside the hospital owns the performance metric this program measures? What does this program require hospitals to do differently, and where does that create a need my solution addresses? And what is the timeline — when do the new requirements take effect, when do penalties begin, and when does the window for proactive investment close?

Those questions, applied to every significant CMS announcement, turn the Federal Register from a compliance document into a prospecting calendar. You know, months in advance, which conversations you need to be having, with which executives, at which organizations, and with what message.

That is not a sales advantage. That is a category advantage. And it compounds every quarter you sustain it while your competitors are still showing up with pitch decks about the shift to value-based care.

THE FLUENCY MOVE

Go to the CMS website and download the most recent HRRP penalty data for the hospitals in your primary market. Identify the three accounts in the highest penalty tier. For each one, note the specific conditions driving their excess readmission rates. Now write one sentence — just one — that connects your solution to that specific condition in the language of the penalty program. If you can write that sentence cleanly, you are ready to make the call. If you cannot, you have found the next gap to close.

This is Part 4 of the series.

Read the previous articles:

You can bring Fluency in Healthcare to your company -

fluentinhealthcare.com

When a hospital CFO tells you the timing is not right, she is not talking about your timeline.

She is talking about five separate conversations happening simultaneously in five separate directions — up to her board, out to her bondholders, across to her accreditation body, down to her operating executives, and sideways to CMS — all of which have to align before a single major purchasing decision can move. Your deal is not stalled because she is busy. It is stalled because you have not yet connected what you are selling to the pressure any of those five conversations are generating.

Most sales teams know about one of the five bosses. They know about the internal hierarchy — the committee, the department head, the C-suite sign-off. They build their sales strategy around navigating that structure. They map the org chart. They find the champion. They work the internal politics.

And they wonder why it still takes fourteen months to close.

The org chart is not the decision architecture. The five bosses are.

Boss One: The Centers for Medicare and Medicaid Services.

CMS does not have an office in the hospital. It does not attend leadership meetings or show up on any org chart. But it is the most influential force in every major purchasing decision a hospital makes, and the sales teams that understand this have a fundamental advantage over every team that does not.

Here is how it works.

CMS sets the reimbursement rules that determine how much revenue a hospital receives for the care it delivers. It sets the quality metrics that determine whether that revenue is enhanced or penalized. It designs the payment models that decide whether a hospital is accountable for costs and outcomes across an entire episode of care or just the inpatient stay. Every time CMS updates a program, adjusts a penalty calculation, or introduces a new payment model, it changes the financial calculus that governs what hospital executives can afford to prioritize, invest in, and buy.

This means that every significant product or service a hospital purchases is evaluated, at some level, against one question: how does this help us perform better under the payment models and quality programs CMS has put in place?

If your solution helps a hospital reduce readmissions, it speaks to HRRP. If it improves surgical episode efficiency, it speaks to TEAM. If it drives quality metric performance, it speaks to VBP. If you cannot articulate which CMS pressure your solution addresses — in specific, quantified terms — you are asking the hospital to make a purchasing decision that lacks regulatory justification. And purchasing decisions without regulatory justification do not get approved. They get deferred.

The fluent seller treats CMS as the first audience for every message they craft. Not the CFO. Not the CMO. CMS. Because if the message holds up against the regulatory logic CMS has established, every conversation downstream becomes easier.

Boss Two: The Bond Market.

This is the boss most sales teams have never thought about at all, and it explains more about hospital purchasing behavior than almost anything else.

Most hospitals in the United States are nonprofit organizations that finance their capital needs — new facilities, major equipment, technology infrastructure — through municipal bonds. Their ability to borrow at favorable rates depends on their credit rating. Their credit rating depends on their financial performance. And their financial performance is scrutinized by rating agencies — Moody’s, S&P, Fitch — that pay close attention to operating margins, days cash on hand, debt service coverage ratios, and the regulatory environment those metrics are exposed to.

What this means in practice is that a hospital CFO is managing not just an operating budget but a credit profile. A deteriorating operating margin does not just create a budget problem. It creates a borrowing problem. A borrowing problem constrains the capital available for facility investment, technology replacement, and program development. A constrained capital position affects the hospital’s ability to compete for patients, physicians, and staff — which feeds back into revenue, which feeds back into the credit profile.

This is why hospital executives are so attuned to margin. It is not just about the current year’s budget. It is about the cost of capital for the next decade.

When your solution helps a hospital protect or improve its operating margin — by reducing penalty exposure, improving reimbursement performance, or lowering operational costs — you are not just solving a budget problem. You are speaking to the credit profile. That is a different conversation. That is a conversation that gets a CFO’s full attention.

Boss Three: The Accreditation Body.

The Joint Commission, DNV Healthcare, the Healthcare Facilities Accreditation Program — hospitals are accredited by independent bodies that evaluate their performance against defined standards for patient safety, care quality, and operational integrity. Accreditation is not optional. Without it, a hospital cannot participate in Medicare and Medicaid. Losing accreditation is an existential event.

Accreditation surveys happen on a cycle — typically every three years, with the possibility of unannounced visits in between. The period leading up to a survey is one of the most operationally intense times in a hospital’s calendar. Leadership attention narrows sharply. Discretionary projects get paused. Vendor conversations that are not directly connected to survey readiness get deprioritized.

The sales team that does not know where its target accounts are in their accreditation cycle will repeatedly schedule meetings at the wrong time and wonder why engagement is low. The team that tracks accreditation timelines knows exactly when to lean in and when to wait — and knows how to frame their solution in terms of accreditation standards when the timing is right.

More importantly, accreditation standards create a vocabulary that hospital quality and compliance leaders speak fluently. If your solution addresses infection control, medication management, patient rights, or any other accreditation domain, there is a specific regulatory language your team should be using in those conversations. Not the general language of quality improvement. The specific language of the standard.

Boss Four: The State Health Department.

The federal regulatory layer gets most of the attention, and rightly so — CMS is the dominant force. But state health departments exercise significant authority over hospital operations, and that authority varies meaningfully from state to state in ways that affect purchasing decisions.

Certificate of Need laws, which exist in roughly half of US states, require hospitals to obtain state approval before making major capital investments in new facilities, services, or equipment. This means that a purchasing decision that would take six months in a state without CON requirements might take eighteen months in a state where it does — not because of internal politics, but because of a regulatory approval process your sales team may not even know exists.

State Medicaid programs, which are administered jointly by states and CMS, have their own quality requirements, managed care structures, and reimbursement rules that layer on top of the federal framework. In states with large Medicaid populations, these state-level rules can be as consequential as the federal ones.

State health departments also conduct their own inspections and licensing activities, with their own calendars and compliance demands. A hospital that is navigating a state inspection cycle is in a similar position to one approaching a Joint Commission survey — leadership bandwidth is constrained and discretionary vendor engagement drops.

The fluent seller knows the regulatory environment of the specific states where their target accounts operate. They know whether CON laws apply, what the state Medicaid structure looks like, and whether any active state health department activity is affecting their accounts’ leadership attention.

Boss Five: The Board.

The hospital board is the governance structure that every CEO ultimately answers to. In nonprofit health systems — which represent the majority of US hospitals — the board includes community leaders, physicians, business executives, and other stakeholders who provide oversight of the organization’s strategic direction, financial performance, and mission alignment.

Board priorities shape executive priorities. If the board has made a strategic commitment to expanding behavioral health services, the CEO and CFO are going to have behavioral health on their agenda in a way that was not there before. If the board is concerned about the organization’s financial trajectory, the CFO’s tolerance for new spending will be lower and the standard of proof required for any major investment will be higher. If the board has adopted a strategic plan with specific goals around quality, access, or community benefit, those goals become the filter through which every significant organizational decision gets evaluated.

Board meetings happen on a schedule — quarterly in most systems — and board reporting creates internal deadlines that shape when executives are available for external conversations and when they are not. The week before a board meeting, a CFO is preparing her financial report. The week after, she is managing action items. The weeks in between are when the real strategic conversations happen.

The sales team that understands the board’s current priorities, and can connect their solution to those priorities, is speaking to the governance layer — the highest level of the decision architecture. That is a different kind of conversation than anything that happens in a procurement review.

How the five bosses work together.

These five forces do not operate independently. They interact, and the interactions create the specific combination of pressures that is shaping your target account’s decision-making right now.

A hospital facing a CMS penalty under HRRP is also managing the impact of that penalty on its operating margin, which affects its credit profile with the bond market, which the board is monitoring, while simultaneously navigating a Joint Commission survey cycle in which readmission rates are a quality indicator, all within a state regulatory environment that may or may not constrain how quickly they can invest in a solution.

That is the actual context of the deal you are trying to close.

The sales team that maps this landscape for each target account before the first conversation is operating in a different world than the team that shows up with a pitch deck and a product demo. They know which pressure is most acute right now. They know which boss is loudest in the room. They know how to frame their solution so it speaks to the pressure that is already driving the conversation at the leadership level.

That is not sophisticated sales technique. That is fluency. And it is learnable.

The mapping exercise that changes everything.

Before your team makes another call to a hospital account, have them answer five questions.

What CMS programs is this health system currently enrolled in, and what are their performance levels on the metrics those programs measure? What is their publicly available financial profile — operating margin, days cash on hand, bond rating if available? When were they last accredited, and when is their next survey cycle likely to occur? What state regulatory environment do they operate in, and are there any active state health department activities affecting them? And what do you know about their board’s current strategic priorities, either from public statements, strategic plans, or annual reports?

If your team cannot answer those questions before a first meeting, they are walking into the conversation without a map. The executive on the other side of the table has been living in that landscape every day for years. The fluency gap opens in the first five minutes — when the rep asks a question that reveals they have not done this work.

The good news is the information is available. CMS publishes performance data on every hospital in the country. Financial data is publicly available for nonprofit health systems through their 990 filings. Accreditation status is public. State regulatory information is accessible. Board priorities are often articulated in annual reports, community benefit statements, and strategic plans that hospitals publish for exactly this purpose.

The fluent seller uses this information not as background research that informs the pitch, but as the foundation of the conversation itself. They walk in already knowing which boss is loudest in the room. And they start talking about that boss before the executive has to bring it up.

That is the moment the executive stops seeing a vendor and starts seeing a peer.

THE FLUENCY MOVE

Pick your single highest-priority target account. In the next 48 hours, find the answers to all five questions above using only publicly available information — CMS data, the organization’s 990 filing or audited financials, Joint Commission accreditation status, state health department records, and the health system’s most recent strategic plan or annual report. Write a one-page brief on which of the five bosses is currently loudest for this account. Bring that brief to your next internal account review instead of a pipeline update. The conversation your team has will be different from any account conversation you have had before.

You can bring Fluency in Healthcare to your company -

fluentinhealthcare.com

This is Part 3 in the Series -

Here are Parts 1 & 2

Learn more about Lisa’s work at: Lisa T. Miller

Every year, thousands of healthcare sales teams sit through the same training.

They learn about active listening. They learn about challenger selling and SPIN methodology and how to navigate a complex buying committee. They learn about building rapport and asking open-ended questions and the importance of a strong follow-up cadence. Some of them learn about value-based care, in a general, conceptual way — the kind of way that lets a rep say we understand the shift to value without being able to explain what HRRP stands for or how a bundled payment actually flows through a health system’s P&L.

Then they go back into the field and lose deals to competitors who can.

The sales leader looks at the results and concludes the team needs more training. So the cycle repeats. More methodology. More roleplay. More pipeline reviews. The win rate does not move. The average sales cycle stays somewhere between nine and fourteen months. The deals that close close because of a champion, not because of the team’s ability to operate at the C-suite level.

This is not a training problem.

It has never been a training problem.

What training solves and what it cannot.

Training solves execution problems. If your rep does not know how to run a discovery call, train them. If they are not following up consistently, build a cadence. If they are pitching too early, coach the sequence. These are real problems and training is the right tool.

But training cannot solve a category problem. And the fluency gap is a category problem.

Here is what that means.

A category problem exists when the market does not yet have language for the problem you solve — or worse, when the market has the wrong language, which causes buyers to sort you into a box you do not belong in. When that happens, no amount of pitch refinement helps, because the issue is not how you are communicating your value. The issue is that the frame your buyer is using to evaluate you is the wrong frame entirely.

Most companies selling into hospitals have a category problem that looks like a sales problem. Their reps are being evaluated as vendors — commodity providers competing on price, relationships, and feature checklists — when they should be entering the conversation as strategic partners to an executive managing federal regulatory pressure. The difference between those two positions is not a matter of how well the rep delivers their pitch. It is a matter of which conversation the rep is even capable of being in.

You cannot train your way from vendor to strategic partner. You have to change the category you occupy in the buyer’s mind. And the only way to do that is to demonstrate, consistently and fluently, that you understand the buyer’s world at a level that makes you useful before the RFP ever gets issued.

The company that names the problem owns the solution.

This is the core principle of category design, and it applies directly to healthcare sales.

Every major shift in how hospitals buy things was preceded by someone naming a problem that the market did not have clear language for yet. When CMS introduced the Hospital Readmissions Reduction Program, it did not just create a financial penalty. It created a named problem — readmission risk — that every hospital suddenly needed a solution for. The companies that moved first to own the language around that problem, to become the authoritative voice on what caused readmissions and what fixed them, captured the category. The ones that showed up later with readmission reduction solutions competed on price.

The same dynamic plays out at the company level. The sales organization that teaches its team to speak in the language of hospital executives — that builds content, frameworks, and conversations around the specific financial and regulatory pressures those executives face — is not just closing more deals. It is designing the category around its own expertise. It is making itself the reference point for a problem the market already has but may not yet have named clearly.

That is a fundamentally different position than being a good vendor.

Good vendors get evaluated. Category leaders get called.

What fluency actually is.

Let me be specific, because this word gets used loosely and it should not.

Fluency is not familiarity. A rep who has been selling into hospitals for ten years and has sat through a hundred leadership meetings is not automatically fluent. Familiarity means you have been in the room. Fluency means you understand what the room is actually about.

Fluency is not vocabulary. Knowing that HRRP stands for Hospital Readmissions Reduction Program is not fluency. Being able to sit across from a CFO and explain precisely which of her DRGs are driving her penalty exposure, and then connect that exposure to a conversation about your solution’s documented outcomes — that is fluency.

Fluency is not enthusiasm for healthcare. Some of the least fluent sellers I have encountered care deeply about the mission of healthcare. Caring is not the same as understanding. The executive on the other side of the table does not need you to believe in what they do. They need you to understand the financial and regulatory environment they are operating in.

Fluency is operational comprehension. It is the ability to walk into any hospital in the country and, within the first ten minutes of a conversation, identify which CMS programs are creating pressure for that organization, which executives own those pressure points, and what a credible solution narrative sounds like in their language. It is the ability to read the room not just emotionally but structurally — to understand why this CFO is asking that particular question, what is driving the concern underneath it, and what answer would move the conversation from evaluation to engagement.

That is a learnable capability. But it is not learned in a sales training. It is built through sustained, structured immersion in how hospitals actually work.

The $100 million company that keeps losing to the scrappy competitor.

I have seen this story play out more times than I can count, and it never stops being striking.

A large, well-resourced company — strong product, credible team, solid market position in adjacent sectors — decides to go after hospital accounts. They hire a VP of Sales with healthcare experience. They build a dedicated sales team. They develop a pitch deck that includes a slide about value-based care and a reference to CMS reimbursement trends. They invest in a CRM, a SDR team, a content marketing function. By every conventional measure, they are well-prepared.

They keep losing deals to a smaller competitor that has a fraction of their resources and a product that, on paper, should not be beating theirs.

The difference is almost always the same thing. The smaller competitor’s team can walk into a hospital leadership conversation and talk about TEAM bundled payments, HRRP penalty tiers, and operating margin compression in the same sentence, with the same fluency that the hospital’s own finance team uses. The larger company’s team has a slide about value-based care. The smaller company’s team has a conversation about the specific problem on the CFO’s desk this quarter.

The larger company diagnoses this as a sales effectiveness problem and schedules more training. The smaller company keeps winning.

This is the fluency gap expressing itself at the competitive level. And it compounds, because every deal the fluent competitor wins makes them more credible in the market, earns them more references, and deepens the category position they are building — while the larger company keeps wondering why their superior resources are not converting into superior results.

The category shift that changes everything.

Here is what happens when a company makes the transition from fluency-as-aspiration to fluency-as-practice.

The conversations change. Not incrementally — fundamentally. Executives who previously scheduled thirty-minute vendor evaluations start scheduling ninety-minute strategic conversations. Deals that used to stall in committee start moving because the executive sponsor has enough confidence in the seller’s grasp of the problem to push them through. The sales cycle compresses not because the team got better at following up, but because the time required to build credibility has been dramatically shortened. Credibility that used to take six months of relationship-building to accumulate now arrives in the first meeting, because the rep shows up already speaking the language.

The referral pattern changes too. Hospital executives talk to each other constantly — at conferences, in peer groups, in the informal networks that exist in every health system market. When a rep shows up in a conversation having already demonstrated genuine fluency, the executives in that room do not just evaluate them for their own accounts. They mention them to their peers. The rep becomes known in the market as someone worth talking to — not because they are likable, though that helps, but because they are useful at a level that is rare.

And the competitive dynamic shifts. Once your team is known as the team that actually understands how hospitals work, you stop competing on features. You stop competing on price. You stop competing on relationships, which are fragile and person-dependent. You compete on something much more durable — the demonstrated expertise that makes your company the obvious choice for any executive who wants a partner rather than a vendor.

That is the category shift. And it starts not with a sales methodology but with a decision to take fluency seriously as a strategic capability rather than treating it as a nice-to-have that good reps develop on their own over time.

The Fluency Gap is a leadership decision.

Here is the thing most sales leaders do not want to hear.

The fluency gap in your organization is not your team’s fault. It is yours.

Your team is selling the way they were hired to sell, trained to sell, and incentivized to sell. If the system they are operating in rewards activity metrics, product pitches, and short-cycle wins over the slower, harder work of building genuine market expertise, they will optimize for activity metrics, product pitches, and short-cycle wins. That is rational behavior.

Closing the fluency gap requires a decision at the leadership level — a decision to invest in building a team that understands healthcare at a depth that most of your competitors have decided is not worth the effort. It requires changing what you measure, what you train, what you hire for, and what you reward.

It requires deciding that fluency is not a feature of your best rep. It is the operating standard for your entire team.

That decision is available to you right now. The chapters that follow will show you exactly what it looks like to act on it.

THE FLUENCY MOVE

Sit in on the next three calls your team makes to hospital executives. Do not coach the pitch. Just listen for the moment when a CMS program, a quality metric, or a regulatory term comes up — from either side. Note whether your rep can engage with it fluently or whether the conversation pivots back to the product. That pivot is your data. Count how many times it happens across three calls and you will have a precise measurement of where your fluency gap starts.

You can bring Fluency in Healthcare to your company -

https://fluentinhealthcare.com

If you missed Part 1 - Start Here:

There is a meeting happening right now in a hospital somewhere in this country.

A CFO, a CMO, and a VP of Supply Chain are sitting around a conference table. They are not talking about your product. They are talking about a CMS penalty notice that arrived last Thursday. They are talking about what happens to their operating margin if their readmission rate does not move by Q3. They are talking about the TEAM model going mandatory next year and what that means for their orthopedic service line.

Your competitor’s rep is in that meeting.

Not because their product is better than yours. Not because they outpriced you, outmaneuvered you, or got there first. They are in that meeting because when the CFO mentioned HRRP six months ago, your rep nodded politely and pivoted back to the product demo. Their rep stopped, asked a very specific question about which DRGs were driving the penalty, and spent the next twenty minutes sounding less like a vendor and more like someone who had sat on the other side of that table.

That is the only difference.

This is not about sales tactics. It is not about closing techniques, account mapping, or how to get past the gatekeeper. There are enough written about those tactics and strategies. This is about something more fundamental — the gap between companies that sell into healthcare and companies that are trusted by healthcare. The gap between being heard and being taken seriously. The gap between having a great product and actually winning the deal.

That gap has a name.

It is called fluency. And most companies selling into hospitals do not have it.

I spent thirty years on the inside of healthcare — managing budgets, evaluating vendors, sitting in the meetings where the real decisions get made. I have seen extraordinary products lose to mediocre ones because the seller could not speak the language of the executive in the room. I have watched sales teams spend twelve months in a sales cycle that should have taken four, because no one on the team could connect their solution to the right pressure point at the right level of the organization.

I am writing about this because it is a solvable problem. Not through a one-day training. Not through a glossary of healthcare acronyms stapled to the back of your sales playbook. Through a genuine, structural change in how your team understands the market it is operating in.

Fluency is not about memorizing acronyms. It is not about putting your team through a compliance training module or adding a ‘regulatory insights’ slide to your pitch deck.

Fluency is about understanding how hospitals work — how they make money, how they lose it, who they answer to, and what keeps their executives awake at three in the morning. When you understand that, something remarkable happens. The conversation changes. The room changes. You are no longer a vendor presenting features. You are a peer presenting solutions to problems the executive already knows they have.

That is the moment deals get made.

The companies that figure this out first will win a disproportionate share of every market they compete in. The ones that do not will keep sending proposals into procurement portals and wondering why nothing is moving.

The market has already decided which kind of company wins in healthcare.

The question is which side of that line you are on.

This substack is Part 1 of a series on this strategy.

Lets begin -

You Are Not Selling to a Hospital. You Are Selling to a Balance Sheet Under Federal Pressure.

Here is something the hospital will never tell you.

When your rep walks in for that first meeting, the executive on the other side of the table is not thinking about your product. They are thinking about a number. Sometimes it is a readmission rate. Sometimes it is an operating margin that has been shrinking for eighteen months. Sometimes it is a CMS penalty they already know is coming and have not yet told their board about. Whatever the specific number is, it sits behind every question they ask, every objection they raise, and every reason they give for why the timing is not right.

Your rep is selling a product. The executive is managing a crisis.

Those two conversations almost never meet — and that is the entire problem this book exists to solve.

The hospital your rep visits is not the hospital that makes decisions.

Walk into almost any major health system in this country and you will find two hospitals occupying the same building.

The first hospital is the one your sales team can see. It has departments and service lines and administrators with titles and org charts and procurement portals. It has a clinical champion who loves your product and a supply chain director who wants three competing bids. It has a budget cycle that starts in September and a committee that meets on the third Tuesday of every month. This is the hospital most sales teams are trained to navigate. This is also the hospital where deals go to stall.

The second hospital is the one that actually makes decisions. It runs on federal reimbursement rules, quality metrics, penalty calculations, and bond covenants. Its real leadership team includes the Centers for Medicare and Medicaid Services, its accreditation body, its bondholders, and its state health department — none of whom show up on any org chart your sales team has ever seen. Every major purchasing decision in this hospital gets filtered through one question before it reaches any other: does this move our numbers in a direction that keeps us viable?

The executives who run this hospital are not being difficult when they slow-walk your deal. They are being rational. They are managing an organization that answers to more bosses than almost any other institution in the American economy, operating on margins that would shut down most businesses in other industries, under regulatory frameworks that change every year and carry eight-figure financial consequences when organizations get them wrong.

Until your team understands that hospital — the real one — you are not in the conversation.

The morning the penalty notice arrives.

Let me show you what I mean.

It is early October. A CFO at a regional health system opens her email and finds the annual Hospital Readmissions Reduction Program update from CMS. The notice tells her that her system’s readmission rate for heart failure patients puts them in the penalty tier for the coming fiscal year. The penalty is $2.3 million — not catastrophic, but still very serious. Even for a system already running a 1.8 percent operating margin, where a $2.3 million penalty does not just affect the budget — it affects what gets delayed, what gets cut, and who has to explain it to the board. She has until her board meeting in six weeks to have a plan.

She does not reach for your brochure.

She calls her VP of Quality. She calls her CMO. She pulls the data on which service lines are driving the readmissions and which patient populations are most at risk. She starts asking questions about what other health systems in her peer group are doing and whether any vendor solutions have actually moved the needle on this metric in a documented, replicable way.

Now. If your rep happens to reach out to this CFO in the next two weeks — with a message that demonstrates a precise understanding of HRRP penalty calculations, that speaks to the specific DRGs most likely driving her readmission rate, and that references documented outcomes from comparable health systems — that rep gets a meeting. Not because they were lucky. Because they were fluent.

If your rep sends a generic outreach about ‘improving patient outcomes through innovative care coordination technology,’ that email gets deleted before she reaches her second cup of coffee.

Same product. Completely different result. The only variable is whether the seller could speak to the problem the executive was actually trying to solve that morning.

Six programs, one mission.

The HRRP story is not an edge case. It is the operating reality for every hospital in the country right now — multiplied across six major CMS programs running simultaneously.

The Hospital Readmissions Reduction Program is penalizing hospitals for excess readmissions across specific conditions, with more than $550 million in penalties distributed annually.

The Hospital Value-Based Purchasing program puts two percent of every hospital’s Medicare reimbursement at risk based on quality and patient experience scores.

The TEAM model — Transforming Episode Accountability Model — is making bundled payment accountability mandatory for surgical episodes at hundreds of hospitals, reshaping how those institutions think about the entire care continuum around a procedure, including every device and technology involved.

The ACCESS program is building a ten-year chronic care infrastructure covering two thirds of Medicare beneficiaries.

The Rural Health Transformation program represents a $50 billion federal investment reshaping how smaller hospitals operate and what they can afford to buy.

The IOTA kidney transplant model creates $15,000 per-case upside for transplant centers that hit performance targets.

Every one of these programs is a commercial opportunity for the right company with the right message. Every one of them is invisible to a sales team that has not done the work to understand what they mean and how they land inside a health system.

The fluent seller reads a CMS program update the way a financial analyst reads an earnings report — looking not just at what it says, but at who inside the hospital now has a new problem to solve, a new budget to justify, or a new metric to move. That is where the conversation starts. That is where the deal begins.

The decision you think you are targeting has already happened.

Here is the part that surprises most sales leaders when I tell them.

By the time a hospital executive agrees to evaluate a vendor solution, the real decision — the strategic decision about what kind of problem needs solving and what kind of investment it warrants — has already been made. That decision happened in a leadership meeting your rep was not in. It happened in response to a regulatory update your rep did not read. It happened because a penalty hit, a quality score dropped, or a new CMS mandate landed that changed the math on something the executive had been deferring for two years.

The companies that are fluent in healthcare are in the room before the formal evaluation starts. They are cited in the leadership conversation. Their frameworks are on the whiteboard. Their language is in the memo the CMO sends to the CFO. They did not get there through better prospecting sequences or more aggressive follow-up cadences. They got there because they had already demonstrated, through every piece of content they published and every conversation their team had, that they understood how hospitals work.

The vendor evaluation that follows is not where they win the deal. It is where they confirm what the executive already decided.

The Fluency Gap and what it is costing you.

The gap between where most healthcare sales teams operate and where they need to operate is not a skills gap. It is not a product gap. It is not a pricing gap.

It is a fluency gap.

And it compounds every quarter. Every meeting where your rep cannot speak to the regulatory context costs you positioning. Every proposal that leads with features instead of financial outcomes costs you credibility. Every sales cycle that stretches to fourteen months because no one on your team could connect your solution to the right pressure point at the right level of the organization — that is the fluency gap expressing itself as lost revenue.

The good news is that this is a solvable problem. Through a genuine, structural change in how your team understands the market it is operating in.

The series that follow will show you exactly what that looks like.

But first, you need to see the full shape of the problem — because the fluency gap is not just a sales team issue. It is a company design issue. And understanding that distinction is what separates the organizations that fix it from the ones that keep scheduling remedial training and wondering why nothing changes.

THE FLUENCY MOVE

Pull the CMS HRRP penalty data for your top five target accounts. It is publicly available. Find the penalty tier each health system landed in for the current fiscal year, identify which conditions are driving their readmission rates, and write a two-paragraph note that connects your solution to that specific pressure — in the CFO’s language, not yours. Do not send it yet. Just write it. If you cannot write it, you have found the gap. That is where the work starts.

You can bring Fluency in Healthcare to your company -

https://fluentinhealthcare.com

In episode seven of “Selling to Healthcare,” Lisa T. Miller tackles what she believes is the number one reason sellers fail at the executive level — they haven’t done the invisible work before they walk into the room. Lisa explores how deep thinking, proximity to the client’s actual work, and foundational thought leadership separate the sellers who get a first meeting from those who keep getting called back.

She shares her framework for earning executive-level conversations — not through louder pitches or better features, but through developing a perspective that names what’s broken and frames solutions in decision language that mirrors how C-Suite leaders actually reason through choices.

Lisa walks through her 5-step process for building foundational thought leadership: finding insight before it becomes obvious, naming implications others miss, writing in decision language rather than marketing language, teaching the shift instead of the answer, and ending with directional tension. She also discusses the power of scheduled thinking time, staying embedded in client operations, and reaching out to executives without a pitch.

This episode offers a comprehensive playbook for healthcare sales professionals who want to move beyond surface-level value propositions and show up as strategic partners whose thinking makes everything else feel obsolete.

Highlights of this Episode Include:

• Think Deeper, Not Louder: Executives don’t buy features — they buy outcomes, consequences, and clarity. The real work happens before you enter the room.

• Escape Maze Thinking: Stop competing to be 10% better and start showing executives that their current frame is outdated.

• Stay Close to the Work: Proximity to the client’s day-to-day operations builds trust, sharpens intuition, and reveals what doesn’t show up in strategy decks.

• 5 Steps to Foundational Thought Leadership: Find insight before it’s obvious, name the missed implication, write in decision language, teach the shift, and end with directional tension.

• Schedule Thinking Time: Carve out distraction-free time weekly to wrestle with hard questions — Lisa’s most significant business breakthrough came from a quiet session with a pen and a blank page.

• Reach Out Without the Pitch: Stay top of mind by offering genuine perspective with no strings attached — executives are starving for someone who thinks about their business without trying to sell them something.

• Decision Language Over Marketing Language: Frame insights around what changes if taken seriously and what doesn’t change if ignored — ask executives to evaluate, not just agree.

You can also listen on -

Learn more about Lisa at https://lisatmiller.com/about

Book an appointment - https://calendly.com/lisa_t_miller/30min

LinkedIn - https://www.linkedin.com/in/lisamiller/

Learn about Lisa’s Workshops:

• https://fluentinhealthcare.com/

• https://healthcaresalesmasterclass.com/

Right now, 65% of Google searches end without a single click. Hospital executives, supply chain directors, and clinical decision-makers are asking ChatGPT, Perplexity, and Google AI Overviews which vendors to consider, which medical devices reduce readmissions, and which companies understand their reimbursement challenges. If your company is not showing up in those AI-generated answers, you are invisible to the people who control hospital purchasing decisions.

This is not a future trend. This is happening today.

The average Google user searches four times a day. The average AI user submits 34 queries a day. The shift is not subtle. Hospital executives who once typed “best surgical robotics vendors” into Google are now asking AI engines, “Which medical device companies help hospitals reduce costs under TEAM bundled payments?” And AI is answering them with citations pulled from a completely different set of signals than traditional search.

What Is Answer Engine Optimization and Why Should Medical Device Companies Care?

Answer Engine Optimization, or AEO, is the strategy of optimizing your content so that AI-powered search engines, including ChatGPT, Perplexity, Google AI Overviews, and voice assistants, directly cite your company when answering questions. It differs from traditional SEO in three fundamental ways.

First, AEO relies on citations rather than backlinks. AI engines are not counting how many websites link to your product page. They are listening to what people say about your company across third-party platforms, in forums, on LinkedIn, in YouTube comments, and in published research. These conversations become the proof points AI uses to decide whether your company is credible enough to recommend.

Second, AEO rewards answers, not keywords. Traditional SEO trained us to bury the answer deep in the page to increase time on site. AI engines want the opposite. They want the answer within the first 100 words of your content so they can extract it and serve it to the user. If a hospital CFO asks an AI engine, “What medical devices reduce 90-day episode costs under CMS bundled payments?” the AI is going to pull from the page that answers that question directly and immediately.

Third, AEO favors freshness over tenure. A page updated within the last 30 days gets cited significantly more often than older content, even if that older content has a stronger backlink profile. For medical device companies selling into hospitals where CMS regulations, reimbursement models, and compliance rules change frequently, this is a major advantage. Your competitors who built static product pages three years ago are losing ground to companies publishing current, regulation-aware content.

Why This Matters Specifically for Hospital Sales

Hospital buying decisions are different from any other B2B sale. A hospital CFO does not evaluate a medical device based on features alone. They evaluate it through the lens of reimbursement impact, regulatory compliance, and total episode cost. When that CFO asks an AI engine, “How do I reduce surgical costs under the TEAM bundled payment model?” they are not looking for a product pitch. They are looking for the company that understands their financial reality.

This is where AEO becomes a competitive weapon for medical device and life sciences companies. If your content answers the specific questions hospital executives are asking, structured with clear headings, backed by data, and published on platforms where real conversations happen, AI engines will cite you as the authority. Your competitors who are still optimizing for “best surgical device” on Google page one are playing a game that is shrinking by the month.

The data backs this up. Traffic from AI-cited sources converts 40% to 300% higher than traditional organic search traffic. Average order values are 30% to 50% higher. Bounce rates drop by 40%. The people who find you through AI are not browsing. They came because a trusted AI engine recommended you. They are ready to engage.

What Medical Device Companies Should Do Now

Here are the specific actions that will position your company to be cited by AI search engines when hospital decision-makers ask questions.

Structure your content around the questions hospitals are actually asking. These are not product-focused queries. They are questions like “How does the TEAM bundled payment model affect device purchasing?” or “What should hospitals look for in a post-surgical monitoring vendor?” or “Which medical devices help reduce 30-day readmission rates?” Write content that answers these questions directly in the first paragraph, then expand with supporting data and case studies.

Build citations on third-party platforms, not just your website. AI engines trust what others say about you more than what you say about yourself. Publish thought leadership on LinkedIn. Contribute expert perspectives in healthcare forums. Get mentioned in industry publications. Participate in conversations on platforms where hospital professionals spend time. AI is using social listening across 81 different platforms to determine who is credible enough to cite. Your website alone is not enough.

Implement schema markup on every page of your website. Schema is the structured data language that tells AI engines exactly what your content is about. Without it, AI may skip your site entirely. Less than 1% of websites currently use proper schema markup. Even fewer use speakable schema, which is specifically designed for voice search and has a 4.5 times better chance of being indexed by AI engines. With 41% of all adults now preferring voice search on their mobile devices, and voice search growing at 200% year over year, speakable schema is one of the largest untapped opportunities in medical device marketing.

Update your content frequently. AI engines prioritize fresh content. This does not mean rewriting everything from scratch. It means updating your articles with the latest CMS regulations, new clinical data, current reimbursement figures, and recent policy changes. A page that references March 2026 TEAM episode pricing data will outperform a page that references 2024 figures, even if the older page has more authority by traditional SEO standards.

Get to the point fast. AI reads headings first and scans for direct answers. If your content buries the answer under five paragraphs of company background, AI will skip it. Lead with the answer. Back it up with data. Then expand for the humans who click through and want the full story.

This Is Already Happening in Hospital Sales

I am not writing about this theoretically. I am already showing up as the cited expert in AI search for selling to hospitals.

This did not happen by accident. It happened because I have been consistently publishing answer-driven, expert content across multiple platforms for years. The AI engines connected the dots across my website, Substack, YouTube, LinkedIn, and published work, and determined that when someone asks about selling to hospitals, my name belongs in the answer.

When someone types “who is the expert in selling to hospitals” into Grok, the AI returns a detailed, seven-point breakdown of my methodology, pulled directly from my content across selltohospitals.com, lisatmiller.com, my YouTube channel, my Substack, and my book Healthcare Sales Mastery: 12 Winning Strategies. It references specific frameworks I teach, from replacing generic pitches with nuanced hospital-specific insights, to mastering C-suite access and language, to developing fluency in CMS strategies and hospital procurement dynamics.In a separate query, an AI engine identified me as “one prominent expert in selling to hospitals” and listed my key areas of focus, including shortening sales cycles, winning larger deals, mastering C-suite selling, balancing patient care with profitability, and understanding hospital procurement, stakeholder mapping, and regulatory fluency. It cited my website, my dedicated selltohospitals.com platform, and my YouTube content as resources. The AI even concluded that I “appear particularly focused and recognized in this niche based on current visibility.”

In a separate query, an AI engine listed my key areas of focus, including shortening sales cycles, winning larger deals, mastering C-suite selling, balancing patient care with profitability, and understanding hospital procurement, stakeholder mapping, and regulatory fluency. It cited my website, my dedicated selltohospitals.com platform, and my YouTube content as resources. The AI even concluded that I “appear particularly focused and recognized in this niche based on current visibility.”

That is exactly the position your company needs to be in when a hospital executive asks AI which medical device vendor to evaluate next.

The Window Is Open, But It Will Not Stay Open

We are in the earliest stages of this shift. For perspective, only 0.03% of websites currently use speakable schema. The majority of medical device companies have not begun optimizing for AI search at all. In most healthcare niches, the first company to build a proper AEO strategy will dominate the AI-generated answers for months, possibly years, before competitors catch up.

The companies that win hospital contracts in 2026 and beyond will not be the ones with the biggest Google Ads budget. They will be the ones that AI engines trust enough to recommend when a hospital executive asks, “Who should we be talking to?”

If your medical device or life sciences company wants to show up when hospital decision-makers ask AI for recommendations, I can help. I work with healthcare companies to build AI search strategies that position them as the cited authority in their space, combining deep hospital sales expertise with the latest AEO and search optimization practices.

If your team is selling into hospitals, there is one capability that separates vendors who get C-suite meetings from those who stay stuck at the departmental level: knowing how CMS policy shapes every financial decision a hospital makes. Most commercial teams have some familiarity with CMS, but the landscape is vast and moves fast. The initiatives are extensive, the financial implications are complex, and hospital executives are operating across all of it simultaneously.

The ability to go deep across every relevant program including TEAM episode accountability, readmission penalties, Value-Based Purchasing, and the $50 billion Rural Health Transformation is what Fluent in Healthcare builds. This strategic workshop, built on 30+ years of experience on both sides of the hospital market, teaches your team how to connect what you sell to the specific financial pressures hospitals are managing right now, at the level of depth that earns executive trust. The result is shorter sales cycles, stronger C-suite access, and conversations that lead with insight instead of features.

Programs are customized to your products, your target market, and your team's current level of CMS fluency. Learn more and schedule a consultation at fluentinhealthcare.com.

Reach out to me directly at lisa@lisatmiller.com or visit lisatmiller.com to start the conversation.

Lisa T. Miller, MHA, is a healthcare sales strategist with over 30 years of experience selling to hospital C-suites. She is the founder of Lisa T. Miller Consulting and the creator of the Fluent in Healthcare program for medical device and life sciences commercial teams.

Many organizations that sell into hospitals invest heavily in training their commercial teams.

Sales professionals learn product science. They understand clinical evidence, competitive differentiation, and the operational workflows their solutions support. They often spend years building expertise within specific service lines or therapeutic categories.

These investments are important and necessary.

But in the hospital market today, there is another capability that is becoming equally important.

Fluency in how hospitals actually make decisions.

Hospitals do not evaluate vendors based solely on product capability. They evaluate solutions within the context of reimbursement, federal policy, margin pressure, and quality performance.

Those forces shape how hospitals allocate capital, prioritize initiatives, and evaluate vendor partnerships.

When commercial teams understand that environment, their conversations with hospitals change in meaningful ways.

They begin discussions where hospital leaders actually make decisions.

That difference is what I call Fluent in Healthcare.

The CMS Strategy Gap

Many healthcare commercial teams are highly capable.

They understand their products. They know their customers. They work in one of the most complex markets in the economy and successfully navigate clinical, operational, and technical discussions every day.

What is often missing is not sales skill.

It is structured fluency in how CMS strategy shapes hospital decision making.

Hospitals operate within an economic environment that is heavily influenced by Medicare reimbursement and federal policy.

Mandatory payment models, quality penalties, reimbursement reforms, and price transparency requirements all influence hospital budgets and strategic priorities.

Most sales training was never designed to teach this layer of the healthcare market.

As a result, even experienced sales professionals may be very well prepared to explain how their solution works but less prepared to connect that solution to the financial and policy forces hospital executives are managing.

That is the real opportunity.

When commercial teams develop CMS strategy fluency, they elevate the conversations they already know how to have.

They position solutions within the financial realities hospitals face.

They engage hospital leadership in more strategic discussions.

And they compete less on product features alone.

How Hospital Executives Actually Evaluate Vendors

Most vendors begin conversations by explaining their product.

Hospital executives begin somewhere else entirely.

They start with financial impact.

In practical terms, hospital leaders tend to evaluate vendor solutions through a sequence that looks something like this.

First comes financial impact.

How does this affect hospital margin?
Does it protect reimbursement?
Will it reduce operating costs or avoid financial penalties?

If the financial impact is unclear, the conversation often stops there.

Second comes alignment with reimbursement and policy programs.

Hospital executives want to know how a solution fits within the payment models and regulatory environment shaping their organization.

Third comes operational impact.

Will clinicians adopt the solution?
Will it improve workflow or reduce complications?

Only after those filters are satisfied do most organizations evaluate product specifications, technical details, and vendor comparisons.

Many vendors begin at the bottom of this stack.

Hospital executives begin at the top.

Fluency in healthcare means understanding that difference and structuring conversations accordingly.

The Structural Forces Shaping Hospital Strategy

Hospitals are not simply operating businesses.

They function within a highly structured economic system shaped by federal reimbursement and regulatory policy.

The Centers for Medicare and Medicaid Services, known as CMS, plays a central role in that system.

CMS determines how hospitals get paid for Medicare patients.

It also determines how hospitals are penalized for poor quality performance or excessive costs.

Over the past decade, CMS has increasingly shifted the healthcare system toward value based payment models.

Instead of rewarding volume alone, these models hold hospitals accountable for cost, quality, and patient outcomes.

As these policies expand, they increasingly influence how hospital leaders evaluate investments.

Understanding these policies allows commercial teams to connect their solutions to the strategic priorities hospital executives are managing.

Major CMS Initiatives Reshaping Hospital Decisions

Several major CMS programs are currently influencing hospital strategy and purchasing decisions.

Understanding these initiatives provides important context for anyone selling into hospitals.

The Transforming Episode Accountability Model (TEAM)

One of the most significant recent policy developments is the Transforming Episode Accountability Model, commonly called TEAM.

TEAM is a mandatory payment model launching in 2026 that places hospitals at financial risk for the total cost of care surrounding certain surgical procedures.

Participating hospitals are accountable not only for the surgical procedure itself but also for costs incurred during the thirty days following discharge.

Those costs can include readmissions, post acute care, skilled nursing facility stays, and other services.

If hospitals manage these episodes efficiently and keep costs below CMS targets, they share in savings.

If costs exceed targets, hospitals face financial penalties.

This model fundamentally changes how hospitals evaluate surgical technologies, care coordination tools, and post acute management solutions.

Products that reduce complications, shorten length of stay, or prevent readmissions become financially meaningful under TEAM.

The Hospital Readmissions Reduction Program (HRRP)

Another longstanding and influential program is the Hospital Readmissions Reduction Program.

Under HRRP, hospitals with higher than expected readmission rates for certain conditions can face penalties of up to three percent across all Medicare inpatient payments.

This penalty structure makes readmission reduction a board level priority for many hospitals.

Solutions that improve discharge planning, patient education, medication adherence, and post discharge monitoring can directly influence performance under this program.

Commercial teams that understand HRRP can position their offerings in ways that clearly connect to hospital financial performance.

Hospital Value Based Purchasing

CMS also operates the Hospital Value Based Purchasing Program, often referred to as VBP.

Under this program, two percent of Medicare hospital reimbursement is withheld and then redistributed based on performance across several quality domains.

These domains include clinical outcomes, patient safety, patient experience, and efficiency of care.

Hospitals that perform well receive additional payments.

Hospitals that perform poorly lose the withheld revenue.

Technologies that improve patient safety, infection prevention, clinical outcomes, or patient experience scores often align directly with these incentives.

Understanding the structure of VBP allows vendors to demonstrate how their solutions influence measurable hospital performance metrics.

Hospital Acquired Condition Reduction Program

The Hospital Acquired Condition Reduction Program penalizes hospitals that perform poorly on safety measures such as infection rates and certain patient safety indicators.

Hospitals in the lowest performing quartile lose one percent of all Medicare payments.

Because this penalty applies across all Medicare revenue, the financial impact can be substantial for larger systems.

Solutions that reduce hospital acquired infections, surgical complications, or patient safety events can help hospitals avoid this penalty exposure.

Site Neutral Payment Reform

Another important policy development is site neutral payment reform.

Historically, services performed in hospital outpatient departments were reimbursed at higher rates than the same services provided in physician offices.

CMS has begun reducing these differences.

For many hospitals, this change compresses revenue in outpatient settings.

As margins tighten, hospital leaders often prioritize investments that improve efficiency, reduce costs, or protect profitability.

Understanding these financial pressures helps vendors position solutions that support operational sustainability.

Rural Health Transformation Program

CMS has also introduced the Rural Health Transformation Program, a major federal initiative providing tens of billions of dollars to support rural healthcare infrastructure and operational transformation.

These funds are intended to support technology adoption, workforce development, and innovative care delivery models.

For companies serving rural hospitals, understanding how this program works can reveal funded opportunities for technology and operational investments.

Price Transparency Enforcement

CMS has also strengthened enforcement of hospital price transparency requirements.

Hospitals must now publish detailed information about negotiated rates with insurers and provide consumer friendly pricing data.

The goal is to increase market transparency and encourage price competition.

For vendors, this environment places greater emphasis on clearly articulating value and return on investment.

Hospitals are increasingly scrutinizing costs across their vendor relationships.

Solutions that can demonstrate measurable financial impact tend to stand out.

Why CMS Fluency Matters for Commercial Teams

The reason these programs matter for vendors is straightforward.

Medicare is the largest payer in the United States healthcare system.

The policies that govern Medicare reimbursement shape how hospitals generate revenue, manage risk, and evaluate investments.

Hospital executives consider these factors constantly.

CFOs analyze reimbursement implications.
COOs evaluate operational efficiency.
Chief medical officers focus on quality performance.

When vendors understand these pressures, their conversations become more relevant.

Instead of presenting a product, they connect their solution to a hospital’s financial and strategic priorities.

This shift often leads to stronger executive engagement and more meaningful discussions.

From Product Pitch to Strategic Conversation

In many healthcare sales interactions, the conversation begins with product education.

The vendor explains the technology.

The hospital evaluates features and compares alternatives.

Eventually the discussion turns to price.

But when commercial teams understand the policy and economic environment hospitals operate within, the conversation often begins differently.

It begins with the hospital’s challenges.

How do we reduce readmissions?
How do we manage episode costs under bundled payments?
How do we improve quality scores?
How do we maintain margin in a changing reimbursement environment?

Solutions that clearly address these questions often receive greater attention from hospital leadership.

The vendor is no longer just explaining a product.

They are participating in a strategic discussion about hospital performance.

The Competitive Advantage of Insight

In competitive markets, information alone rarely differentiates vendors.

Every company can present product data and clinical evidence.

Insight connects that information to the problems executives are actively trying to solve.

When a vendor demonstrates an understanding of the reimbursement environment shaping hospital decisions, it signals credibility.

It shows that the company understands the customer’s operating reality.

This type of insight often leads to deeper engagement with hospital leadership and more productive discussions about long term partnership.

The Future of Selling to Hospitals

Healthcare policy will continue evolving.

Payment reform, value based care models, and quality measurement programs will remain central to how hospitals operate.

As these forces expand, the expectations placed on vendors will evolve as well.

Hospital leaders increasingly value partners who understand the economic and regulatory environment shaping their organizations.

They respond to vendors who bring perspective and insight, not just products.

Fluency in healthcare is ultimately about understanding the system hospitals operate within.

Because in the hospital market, understanding the product is important.

Understanding the environment that shapes hospital decisions is what turns that knowledge into strategy.

Fluent in Healthcare Workshop

Fluent in Healthcare is a first of its kind strategic program designed for commercial teams that sell into hospitals and health systems. Developed from more than three decades of experience advising hospital leadership and closing enterprise healthcare deals, the program teaches a capability rarely addressed in traditional sales training: how to interpret CMS policy, reimbursement structures, and hospital financial strategy through a commercial lens.

Participants learn how hospital executives actually evaluate investments, how federal payment initiatives and quality programs shape purchasing decisions, and how to position solutions within the economic forces governing hospital performance. The result is a level of strategic fluency that allows commercial leaders to move beyond product conversations and engage the hospital C suite with insight, credibility, and a deep understanding of the environment in which healthcare decisions are made.

Learn more: https://fluentinhealthcare.com

I had a conversation today that stopped me in my tracks.

I was speaking with a hospital executive I know well — someone sharp, financially sophisticated, genuinely committed to improving his organization. He had been evaluating a new technology platform to manage a critical area of his hospital’s operations. The potential financial improvement was significant. Not incremental. Significant.

And then he said it: “We’ll probably not move forward with it.”

Not because the technology didn’t work. Not because the ROI wasn’t there. Not because a competitor won. He couldn’t get internal buy-in. There was no burning platform, no crisis forcing the decision, and without that urgency, the organization simply couldn’t summon the collective will to act.

I was stunned — not by the outcome, but by how preventable it was. What I heard was not a buyer who rejected a solution. It was a buyer whose vendor had failed to take him on a decision journey. They never equipped him with the tools to build consensus internally. They never gave him the language, the data, or the framework to champion this to the people who needed to say yes. They left him to sell it alone.

This is Stalled Deals Syndrome. And if you sell into hospitals, you are living this every single day.

The Most Expensive Problem Nobody Is Talking About

After 25 years of selling into hospital C-suites and closing more than $200 million in executive-level sales, I can tell you with certainty: stalled deals are the most expensive, most overlooked problem in healthcare sales.

Research across millions of sales conversations shows that 40 to 60 percent of B2B deals end not with a competitor winning, but with no decision at all. In healthcare, where buying cycles are longer, stakeholder groups are larger, and capital budgets are fiercely contested, that number likely runs even higher.

Most sales leaders treat this like a closing problem. It’s not. It’s a decision problem. And until you understand the difference, you will keep losing to organizational inertia — not to the competition.

The Real Enemy in Healthcare Sales

The majority of deals lost in hospital sales were not taken by another vendor. They were killed by the buyer’s own inability to decide — by the fear of making the wrong decision in an environment where every dollar is scrutinized and every executive who champions a failed initiative carries that scar for years.

Traditional sales training says create urgency. But when a hospital executive already sees the value and still cannot move — like the executive I spoke with today — urgency is not the problem. More demos and case studies only increase the cognitive load on a buyer already overwhelmed by competing priorities.

The research is striking: re-selling the value proposition to an indecisive buyer had a negative effect in 84 percent of attempts.

Two Problems, Two Playbooks

The critical diagnostic skill is distinguishing between status quo resistance and indecision.

A hospital CFO resisting the status quo says, “We’re managing fine with our current process.” That buyer needs urgency. An indecisive buyer says, “Let me think about it,” or goes silent, or — like my conversation today — says, “We probably won’t move forward,” even though they know they should. That buyer already sees the value. They need fewer reasons to be afraid and a clear path through their own organization.

Where overcoming the status quo is about dialing up the fear of not purchasing, overcoming indecision is about dialing down the fear of purchasing. Using the wrong playbook makes things worse.

Why Value Selling Alone Will Never Close Hospital Deals

The sales industry assumes that if you demonstrate enough value, the deal closes. I have watched this fail in healthcare over and over. A company proves ROI, demonstrates self-funding, gets clinical endorsement, and two years later the deal is still stalled.

Because deals that close in hospitals have three elements aligned. I call them the Three V’s: Value, Vision, and Voice. Value is the ROI and business case. Vision is the bigger picture of what this decision enables for the health system — and it must be shareable internally. Voice is your unique differentiation.

Complex hospital sales are combination locks, not keyholes. The CFO needs value. The COO responds to vision. The CMO or CNO cares about clinical outcomes and differentiation. Miss the right V for the right person, and the deal stalls — not because they rejected you, but because nobody could build enough internal momentum.

That executive I spoke with today? His vendor had proven value. But they never established vision at the C-suite level, and they never gave him the voice to champion the decision internally.

The Pipeline Map: Where Hospital Revenue Gets Trapped

Your pipeline is not a single funnel. It is three distinct zones, and each requires entirely different skills and strategies.

The Break-In Zone is where most of the investment lives: getting access, landing the meeting, securing the pitch. BDRs, marketing campaigns, conferences — the entire industry is built around this. Important work, but it is only the beginning.

The Executive Yes is the signed contract, the purchase order. Some attention is paid here — closing skills, negotiation tactics, contract management.

But the middle — what I call the Decision Zone — is where the most revenue gets trapped. You have broken in. The meeting happened. The proposal was sent. Now the deal enters the hospital’s internal decision process. This is where everything happens: competing capital requests emerge, naysayers appear, IT raises a thousand security questions, budgets get reshuffled, and the telephone game dilutes your value proposition with every retelling. Your champion tries to carry your message to people you will never meet, and it gets weaker every time it changes hands.

Most teams treat this as the dead zone — a place where you wait and follow up. That is the fundamental mistake. The vast majority of sales resources, training, and education live in the Break-In Zone. Some attention is paid to the Executive Yes. Almost nobody addresses the Decision Zone. And that is where the most money is sitting, the most pain is concentrated, and the most strategic work needs to happen.

Why “Fortune Is in the Follow Up” Is Making Things Worse

The conventional wisdom for stalled deals is more follow up. Send an article. Send a gift. Check in. Add value. Show them you are thinking of them. The entire sales industry says the fortune is in the follow up, and that if you just persist long enough, the deal will eventually close.

Here is what I have learned from decades of selling into hospitals: almost all of that advice is about value-led follow up. It is designed to keep you visible and demonstrate you are helpful. Send a relevant article. Share an introduction. Forward an industry report. These are all well-intentioned — and when a deal is stalled in the Decision Zone, every single one of them feeds the stall.

Why? Because value-led follow up does not address the actual reason the deal is stuck. The buyer is not stalled because they forgot about you or because they need more evidence that you are smart. They are stalled because there are three people inside their organization who have not been aligned, or because nobody translated your value proposition into language the CFO can act on, or because there is a naysayer in IT who was never addressed, or because your champion does not have the tools to make the internal case.

The buyer looks at your article, your case study, your thoughtful note, and thinks, “That’s nice.” And nothing moves. Because nothing you sent moved the decision forward. You stayed visible, but the barrier — the actual thing preventing a yes or no — is exactly where it was before.

What moves deals is decision-led follow up. Follow up that is specifically designed to advance the buyer’s internal decision process — to identify and address the next barrier standing between where they are and a yes or no. Not another touchpoint. Not another proof of value. A deliberate step that moves the decider’s journey forward.

That means your follow up looks radically different depending on what is actually stalling the deal. If the deal stalled because you sold too low and there is no executive sponsor, your next step is not an article — it is a strategy to re-engage at the C-suite level. If the deal stalled because your value proposition got lost in the telephone game, your next step is narrative transfer tools — a one-page executive summary, a short video overview, an ROI calculator that lets your champion make the case without improvising. If the deal stalled because a naysayer in IT raised concerns that were never addressed, your next step is a comprehensive security document delivered before it is even requested. If the deal stalled because your data is getting stale, your next step is to use the hospital’s own numbers — request a spend report, utilization data, or clinical metrics, analyze it, and re-engage with insights from their data that make you impossible to dismiss.

Decision-led follow up requires you to diagnose the specific friction point first, then design a response that directly addresses it. That is a fundamentally different discipline than adding value. It is strategic. And it is what separates companies that move deals from companies that nurture them into oblivion.

The Shift That Changes Everything

That executive I spoke with today did not need another demo. He needed his vendor to understand that proving ROI was only the beginning — and that the real work was helping him navigate the internal decision journey he was facing alone.

Every deal sitting in your hospital pipeline right now is not dead. It is stuck. Pull every deal that has not moved in 30 days. Quantify the total dollar value. Then ask: is the buyer stuck because they prefer what they have, or because they are afraid of what comes next — and you left them without the tools to get there?

The answer will tell you everything you need to know.

If This Is Your Pipeline, Let’s Talk

I work with companies selling into hospitals who have pipeline — but cannot get it to move. Through Healthcare Sales Masterclass, I deliver custom workshops that help sales teams diagnose exactly where and why their deals are stalling, build a decision-led process around the Decision Zone, and equip their champions with the tools to navigate the internal buying journey. If your team is sitting on millions of dollars in mid-pipeline revenue and the follow-up playbook is not working, this is the work I was built for. Reach out at lisa@lisatmiller.com and let’s look at what is stuck.

Lisa T. Miller provides strategy and training to companies selling into hospitals, with a focus on accessing the C-suite and moving stalled deals through the pipeline. Through Healthcare Sales Masterclass (healthcaresalesmasterclass.com), she delivers custom workshops on unstalling deals, executive-level selling, and building the Decision-Led Deals framework into sales team operations.

Lisa is the author of The Executive Yes and creator of the Decision-Led Deals and C-Suite Selling System methodologies. She built and sold a healthcare consulting firm that delivered over $1 billion in documented savings for hospitals and has personally closed more than $200 million in executive-level sales across a 25-year career competing against billion-dollar firms. If your team is selling into health systems and leaving revenue stuck in the middle of the pipeline, reach her at lisa@lisatmiller.com.

https://healthcaresalesmasterclass.com

https://executiveyes.com

https://www.sead-system.com

Most deals do not fail because the solution is wrong.

They fail because the decision never fully forms.

What looks like hesitation is often something else entirely. Unresolved risk. Competing priorities. A lack of internal clarity. Or a decision that never truly rose to the level where a yes could be owned.

This is the part of enterprise selling that rarely gets named.

By the time you are presenting to senior leadership, the executive is no longer evaluating features, value propositions, or even ROI in the way most sellers expect. They are weighing exposure. They are thinking about what this decision commits them to, what it displaces, and how it will hold up when questioned later by a board, peers, or investors.

That is why deals stall after good meetings.

Everyone leaves aligned.
Everyone agrees it makes sense.
And still nothing moves.

At the executive level, agreement is not the same thing as a decision.

Over the last three decades, I have watched this play out thousands of times, first as a seller, then as an advisor working directly with CEOs, CFOs, COOs, and executive teams. I saw capable professionals do everything right according to traditional sales advice and still lose momentum the moment the conversation moved upward.

The pattern was consistent.

People were selling into the C suite without understanding how executives actually decide.

Executives do not say yes because they are persuaded.
They say yes when the decision feels defensible, coherent, and safe to stand behind.

That distinction changes everything.

Once you see it, you stop trying to push deals forward and start shaping the conditions under which a decision can happen. You stop chasing alignment and start creating clarity. You stop positioning yourself as a vendor and begin showing up as someone who understands what is truly at stake.

That shift is what I call The Executive Yes.

And it is the reason I wrote this book.

Announcing The Executive Yes

I am excited to officially share my new book, The Executive Yes: The Art and Science of Closing Transformational Deals at the Top.

This book is for CEO’s, sales professionals, founders, and advisors who already know their work creates value, but are frustrated by long sales cycles, stalled decisions, and polite executive interest that never turns into a real commitment.

It is not a book of tactics or scripts.
It is a system for understanding executive decision making from the inside out.

Inside, I break down how executives evaluate risk, how decisions actually move through large organizations, why consensus does not travel upward, and what separates conversations that feel productive from those that quietly die.

If you sell complex, high value work into enterprise environments and want to stop chasing decisions that never materialize, this book was written for you.

The executive yes is not about pressure.
It is about clarity, judgment, and relevance.

And once you understand how it works, you stop waiting for decisions and start shaping them.

Order The Executive YES Book

I approach foundational thought leadership as an act of synthesis, not persuasion.

When I write a primary thought leadership piece for hospital executives, the goal is to introduce a way of understanding the environment they operate in, grounded in evidence across clinical performance, business operations, and financial accountability. This is not content designed to capture attention in a crowded feed. It is designed to be durable, referenceable, and useful over time.

Hospital executives are, by nature, builders. They choose roles defined by complexity, tradeoffs, and long time horizons because they want to shape systems that matter. They are intellectually curious, but their curiosity is disciplined. It is oriented toward understanding how forces outside the organization are changing what leadership inside the organization requires.

A core thought leadership piece should respect assume sophistication, not try to create urgency where none exists. Its value comes from helping an executive see a familiar challenge more clearly by connecting domains that are usually considered separately.

Step One: Finding Insight Before It Becomes Obvious

The most important decision I make when creating a core thought leadership piece is what not to read.

I deliberately stay away from blogs, opinion pieces, and recycled commentary. Not because they lack intelligence, but because they tend to flatten complexity. By the time an idea appears repeatedly in commentary, it has usually already lost the nuance that makes it useful to senior leaders.

Instead, I work across primary sources that sit at different altitudes of the system. CMS rulemaking and subregulatory guidance to understand how accountability is being defined. Hospital cost and utilization data to see where performance is actually moving. Earnings calls and financial disclosures from for profit health systems to hear how executives explain results when they are accountable to markets. Peer reviewed clinical and health services research to understand what actually changes outcomes, not what is assumed to.

What I am looking for is not agreement across these sources. I am looking for misalignment.

That misalignment is the signal.

It shows up when clinical evidence points in one direction, operational practice lags behind, and financial accountability quietly moves anyway. When you see the same tension from multiple vantage points, it stops being academic. It becomes strategic.

Bundled payment guidance is a good example. On the surface, it describes program mechanics. Read closely, and something else emerges. Hospitals are no longer being evaluated solely on the care they deliver inside their walls. They are being judged on whether recovery itself is shaped, supported, and stabilized after discharge.

That expectation is not announced. It is embedded.

When you surface an embedded expectation like that and connect it to clinical outcomes, operating models, and financial exposure, you are no longer offering commentary. You are giving executives information they can use to run the organization differently.

That is the difference between content and foundational thought leadership.re.

Step Two: Naming the Implication Others Miss

The goal of research is not to confirm what everyone already knows. It is to find the implication that has not been fully articulated.

In the case of financial performance, the under discussed insight is that recovery is no longer downstream. It is upstream to margin, quality scores, and long term service line economics.

Most hospitals still organize around episodes that end at discharge. Policy and reimbursement logic no longer do.

That is the kind of nuance executives engage with.

Step Three: Write in Decision Language, Not Marketing Language

Once the insight is clear, the work shifts from analysis to judgment.

At this point, I am no longer writing to inform. I am writing to mirror how senior executives actually reason through choices. That means the language on the page has to resemble the language used in operating reviews, capital allocation discussions, and board conversations.

I am not describing possibilities. I am defining implications.

The writing is structured around what changes if this insight is taken seriously and what does not change if it is ignored. Where risk begins to accumulate. Where performance becomes harder to predict. Where existing investments start to deliver diminishing returns because the environment they were designed for no longer exists.

This is why I avoid benefit led framing. Marketing language asks the reader to agree. Decision language asks the reader to evaluate.

Executives do not need to be persuaded that something is important. They need to see how it alters the set of decisions they are responsible for making. When the writing does that well, it creates clarity without instruction and urgency without exaggeration.

Step Four: Teach the Shift, Not the Answer

Foundational thought leadership is not where solutions are announced. It is where mental models are updated.

I show how yesterday’s logic produced today’s results and why tomorrow’s environment will reward different decisions. I connect policy, finance, and operations without oversimplifying any of them.

That is where insight lives.

Step Five: End With Directional Tension

The purpose of a foundational thought leadership piece is not to resolve the issue it introduces. It is to leave the reader with a clearer understanding of the constraint they now operate within. In this case, hospitals are increasingly evaluated on outcomes that extend well beyond the point where traditional management systems stop, creating a growing gap between responsibility and control.

That tension does not call for urgency or optimism. It calls for leadership. When a piece ends this way, it stays with the executive not as an idea, but as a question that must eventually be answered in strategy, structure, and investment decisions.

Foundational thought leadership for hospital executives is not created by having a louder point of view. It is created by doing the harder work of reading the system as it actually operates, across clinical evidence, operational reality, and financial accountability, and then naming the implications before they become obvious. When done well, this kind of writing does not tell executives what to think or what to do. It gives them a clearer frame for understanding the decisions they are already responsible for and the constraints they can no longer ignore. That is what makes a core thought leadership piece durable, referenceable, and valuable long after it is read.

P.S. Need some quick help?
​Browse my ​free resources​ and ​paid program​.

New! Healthcare Sales Masterclass - Join the waiting list:

Selling into healthcare is one of the most misunderstood disciplines in enterprise sales.

Many people assume the challenge lies in product maturity, pricing, or brand recognition. In reality, most healthcare deals stall for a far more fundamental reason. Sellers have not been trained to understand how healthcare organizations actually make decisions, manage risk, or justify change internally. Without healthcare specific sales training, even experienced professionals find themselves active but ineffective.

Healthcare is not a single buyer.

It is an ecosystem of clinical leaders, operational executives, financial stewards, compliance teams, IT security, supply chain, and legal stakeholders. Each group evaluates decisions through a different lens and answers to different forms of accountability. A solution that excites one group can quietly trigger resistance in another. Sellers who do not understand these internal dynamics often spend months building relationships that feel productive but never convert into enterprise momentum.

What makes healthcare selling uniquely difficult is not just complexity but consequence.

Decisions carry downstream impact on patient safety, quality scores, regulatory exposure, staffing models, and financial performance. Because the stakes are high, healthcare organizations are structurally conservative. They do not reward novelty. They reward confidence, clarity, and control. Sellers who approach healthcare with a standard enterprise sales mindset quickly discover that enthusiasm does not equal approval and interest does not equal progress.

This is why selling into healthcare requires a different operating system.

Discovery is not about finding pain. It is about understanding how problems show up across clinical outcomes, financial performance, and operational flow. Messaging is not about differentiation alone. It is about framing change in a way that reduces perceived risk and increases organizational confidence. Progress is measured not by meetings booked but by alignment built across decision layers.

One of the most misunderstood stages in healthcare sales is what sellers often call validation. Healthcare organizations do not move forward because something works in isolation. They move forward when they believe the organization can absorb the change without disruption. Sellers who lack training often mistake positive feedback as readiness. In reality, healthcare leaders are quietly assessing governance, ownership, scalability, and long term accountability. When those questions are not proactively addressed, momentum fades even after early success.

Another major reason healthcare deals stall is the misunderstanding of internal process.

Compliance, security, legal review, and contracting are not obstacles that appear at the end of the sales cycle. They are built into how healthcare organizations protect themselves. Sellers who are not trained in healthcare procurement often engage these functions too late or without context. This creates delays, resets conversations, and introduces unnecessary friction at precisely the moment when confidence should be increasing.

At the executive level, healthcare selling becomes a test of judgment. Senior leaders are not asking for demos or feature comparisons. They are asking whether this decision strengthens the organization, protects patients, and aligns with long term strategy. They want to know what happens if this fails, who is accountable, and how success will be measured over time. Sellers who are not trained for these conversations often over explain or under answer, eroding confidence without realizing it.

The most successful healthcare sellers rely on structure.

They understand where deals stall and why. They know how to maintain momentum in long cycles without over chasing. They recognize that healthcare buyers are not avoiding decisions. They are avoiding regret. When sellers learn how to remove regret from the decision equation, deals move.

This is why healthcare sales is a discipline that must be learned deliberately. Experience alone is not enough if it is unstructured. Trial and error is expensive in a market where sales cycles routinely exceed twelve months and access to senior leaders is limited. A proven system accelerates learning by making the invisible visible and the complex navigable.

What Does Healthcare Sales Training Teach?

• How to think like an executive sponsor. It teaches sellers how to speak in outcomes rather than tactics, how to quantify impact credibly, and how to connect solutions to strategic priorities like access, efficiency, quality, and sustainability. This is what transforms a seller from a vendor into a trusted partner.

• How to establish decision ownership early, how to clarify success in terms executives care about, and how to frame next steps as organizational commitments rather than informal trials. The goal is not to prove the solution works. The goal is to make it easy for the organization to say yes without fear.

• Training teaches how to prepare documentation before it is requested, how to align messaging across clinical and administrative stakeholders, and how to position these reviews as confirmations rather than hurdles. When sellers understand the rhythm of healthcare buying, deals move forward with far less resistance.

If you are selling into healthcare and want to shorten sales cycles, gain real executive access, and close enterprise contracts with confidence, the Healthcare Sales Masterclass is built for exactly that purpose. Led by Lisa T. Miller, who has spent more than three decades selling to and advising healthcare executives, this March cohort will teach the frameworks, language, and decision logic that healthcare organizations actually respond to. The program is limited to a small group to ensure depth, application, and real world relevance.

You can learn more and join the waitlist at Healthcare Sales Masterclass.

The #1 Healthcare Sales Training Program for Enterprise Success

The proven healthcare sales training system for anyone selling into healthcare to master enterprise sales, navigate complex procurement, and close health system contracts.

P.S. Need some quick help?
​Browse my ​free resources​ and ​paid program​.
​

The Evolution of Value Selling to Decision Led Selling

For more than two decades, value selling has been the dominant philosophy in professional sales. Entire methodologies, certifications, books, and training programs have been built around a simple and powerful idea. If sellers can clearly articulate value in terms that matter to the buyer, deals will close, margins will hold, and long term relationships will follow. In many environments, that idea has proven true.

But something has changed. Not in the importance of value, but in how decisions actually get made.

Despite widespread adoption of value selling frameworks, enterprise deals continue to stall late. Sales cycles stretch. Executive sponsorship weakens. Buyers agree that something is valuable and still do nothing. This gap is not a failure of execution. It is a signal that value selling, as it is commonly taught, no longer fully maps to modern decision dynamics.

Value selling is necessary. It is no longer sufficient.

At its core, value selling teaches sellers to shift conversations away from features and price and toward outcomes, impact, and return. Done well, it elevates the seller from vendor to business partner. Books like The Power of Value Selling by Julie Thomas reflect the best of this evolution. They emphasize customer centricity, trust, human connection, and business relevance. They help sellers compete on value rather than discounting. They improve the quality of conversations and protect margin.

Where value selling begins to fall short is not in explaining value, but in navigating choice.

Modern buyers, especially senior executives, are not short on valuable options. They are drowning in them. Every initiative presented to an executive is framed as strategic, urgent, and high impact. Digital transformation, cost containment, growth acceleration, risk mitigation, talent enablement, innovation, and compliance all arrive pre packaged as value.

Executives rarely ask whether something is valuable. They ask whether it deserves priority.

Value selling answers the question of worth. It does not answer the question of precedence.

This distinction matters because enterprise decisions are not made in isolation. They are made in environments defined by limited attention, political capital, internal resistance, and reputational risk. An executive can believe in the value of a solution and still decide not to act because the internal cost of championing it feels too high.

Traditional value selling assumes a linear path from value recognition to purchase. In practice, the most dangerous part of the sales process happens after value is agreed upon. That is where deals quietly die.

Decision Led Selling emerges precisely at this point.

Decision Led Selling is the evolution of value selling into the discipline of guiding how decisions are made, not just why something is valuable. It recognizes that once value is established, the seller’s role shifts. The work is no longer persuasion. It is enablement.

In Decision Led Selling, the seller leads with decision context rather than solution merit. The focus moves upstream to understanding what else is competing for executive attention, what risks the buyer is managing, and what internal dynamics will determine whether a decision survives scrutiny beyond the meeting.

This approach reframes the seller’s role from value messenger to decision partner.

One of the core limitations of value selling is its treatment of risk. Value selling tends to frame risk in economic or performance terms. Will the solution deliver the promised outcomes. Will the return justify the investment. Executives think about a different kind of risk. Political risk. Organizational risk. Reputational risk.

They are asking questions that rarely surface in sales conversations. Who will push back on this. Which peers will feel disrupted. What happens if this fails publicly. What initiatives does this displace. Who owns the fallout if it goes wrong.

Decision Led Selling brings these questions into the open rather than hoping they resolve themselves. By naming internal friction early, the seller reduces perceived risk and builds credibility. Avoiding complexity does not make it disappear. Addressing it builds trust.

Another place value selling falls short is narrative portability. Sellers are trained to present value convincingly in the room. Executives need a story they can repeat when the seller is not there. In board meetings. In peer discussions. In downstream leadership conversations.

If the value story cannot travel, the decision cannot survive.

Decision Led Selling focuses on helping executives articulate a simple, defensible decision narrative. Why this initiative matters now. Why it deserves priority over other valuable options. Why this approach and this partner make sense. This narrative coherence is often the difference between momentum and stall.

Importantly, Decision Led Selling does not abandon selling. It elevates it.

This is still selling. But it is selling at the level where enterprise outcomes are determined. Instead of optimizing for agreement, it optimizes for commitment. Instead of closing the deal, it helps the executive close the internal loop.

In this model, value is the entry ticket, not the destination.

Decision Led Selling assumes the seller is fluent in value. That foundation matters. But it recognizes that the hardest part of the sale is not convincing the buyer. It is helping the buyer choose, align, and act.

The evolution from value selling to Decision Led Selling reflects a broader shift in modern enterprise environments. Complexity has increased. Decision velocity has slowed. Accountability has intensified. The cost of visible failure has risen.

Decision Led Selling is a sales discipline that shifts the focus from proving value to guiding how executive decisions are made.

Instead of leading with product benefits, ROI, or solution differentiation, Decision Led Selling begins with a deep understanding of the buyer’s decision environment. The seller prioritizes how executives evaluate tradeoffs, manage organizational and reputational risk, align stakeholders, and choose among multiple initiatives that are all objectively valuable.

In Decision Led Selling, value is assumed. The work is helping the buyer decide.

This approach teaches sellers to operate upstream of the purchase by shaping decision context before requirements are finalized and buying processes harden. Sellers help executives clarify what matters now, what can wait, and what makes a decision defensible inside the organization. The emphasis shifts from justification to prioritization.

Decision Led Selling reframes the seller’s role from persuader to decision architect. The seller actively reduces internal friction, surfaces hidden objections early, and helps construct a clear decision narrative that executives can carry into peer discussions, board conversations, and downstream leadership meetings without the seller present.

At its core, Decision Led Selling answers a different question than traditional value selling.

Value selling asks why should we buy this.

Decision Led Selling answers why is this the decision we should make now and stand behind.

It is still selling. But it is selling at the level where enterprise decisions actually get made.

In this context, the sellers who win are not those who explain value best. They are the ones who make decisions feel obvious, defensible, and safe to champion.

As sales organizations look toward the future, the question is no longer whether value matters. It does. The question is whether sellers are equipped to operate where value alone no longer moves decisions forward.

Executives expect value.

How can you help them move the decision throughout their organization?

Helping them do that requires a shift from selling the solution to enabling the decision.

First, help them clarify the decision, not just the initiative.
Executives need a clear statement of what is being decided and why it matters now. When the decision itself is fuzzy, alignment breaks down. Sellers who help executives sharpen the decision frame give them something concrete to socialize internally.

Second, surface internal resistance before it appears.
Executives know where friction will show up, but they rarely name it in sales meetings. Ask where pushback is likely to come from, what teams will feel disrupted, and what concerns will surface late. Addressing resistance early lowers risk and builds trust.

Third, help them prioritize against competing initiatives.
Most decisions stall because they are competing with other valuable efforts. Help executives articulate why this initiative deserves attention now versus later. This is about timing and tradeoffs, not value proof.

Fourth, give them a repeatable narrative.
Executives need a simple, defensible story they can repeat to peers, boards, and teams. Not a pitch. A rationale. Why this, why now, why this approach, and why this partner. If the story cannot travel without you, the decision will not move.

Fifth, reduce the perceived cost of sponsorship.
Executives evaluate how much political capital and personal risk a decision requires. Help them see how the decision can be staged, tested, or contained. Lowering exposure makes action feel safer.

When you do this, you stop being the person who explains value and become the person who helps decisions move. That is the difference between agreement and momentum.

Learn More:

The Best Value Selling Methodologies for Enterprise Leaders

Selling to Healthcare

P.S. Need some quick help?
​Browse my ​free resources​ and ​paid program​.

If you’re selling high-value enterprise deals and wondering why conversations keep stalling at mid-levels, it’s not your offer — and it’s not your selling skill.

It’s access design.

Enterprise buyers are:

      •     Harder to reach

      •     More risk-averse

      •     Slower to decide

      •     Less responsive to traditional “selling”

Most companies try to push harder.

That’s the mistake.

Enterprise deals don’t fail because of effort

They fail because of structural blockers:

      •     The wrong buyers are being targeted

      •     Senior access is happening too late

      •     Positioning sounds tactical instead of strategic

      •     Differentiation isn’t defensible at executive level

      •     Fulfilment and internal readiness raise quiet risk flags

Until those are fixed, no amount of follow-up, persuasion, or funnel optimisation changes the outcome.

This is exactly what SEAD™️ does

SEAD™️ — Strategic Enterprise Access for Deals shows you:

      •     Why your enterprise deals are stalling

      •     Which barrier is blocking progress first

      •     What must change to unlock senior access

      •     How to move from mid-level conversations into decision rooms

This is not training.

It’s not theory.

It’s a private strategic analysis applied directly to your business.

SEAD™️ is for:

      •     Companies selling complex, high-value enterprise deals

      •     Long sales cycles ($250K–$1M+)

      •     Multi-stakeholder buying environments

It is not for:

      •     SMB funnels

      •     Transactional sales

      •     Early-stage experimentation

If enterprise growth is a priority — this is the starting point.

Access SEAD™️ here

Healthcare sales does not fail because the product is weak or the pricing is wrong. It fails much earlier. It fails when sellers underestimate the complexity of hospitals and overestimate the power of a pitch.

Selling into hospitals and health systems is not traditional selling. It is not transactional. It is not fast. And it is never just about the solution. It is about navigating risk, trust, culture, and competing priorities inside some of the most complex organizations in the economy.

They are patterns that show up again and again in deals that move forward and deals that stall.

Here is what mastery really looks like.

1. Build trust before you sell anything

In healthcare, trust is the entry ticket. Leaders are responsible for patient outcomes, regulatory exposure, and financial stewardship. They do not experiment lightly.

Trust is built through proof, consistency, and credibility. Case studies matter. References matter. A professional digital presence matters. Most of all, your mindset matters. Healthcare organizations want partners who will still be accountable after implementation, not vendors chasing a signature.

2. Customize your approach every time

Every hospital looks similar from the outside and operates very differently on the inside. Service lines, leadership dynamics, margins, and risk tolerance vary widely.

Effective sellers research deeply before the first conversation. They tailor their narrative to the organization, not the market. They listen carefully and adapt in real time. One size does not fit any hospital.

3. Make the financial case executives actually trust

Budgets are tight in healthcare, but budget objections are rarely just about money. They are about confidence.

Strong financial cases use conservative assumptions, clear data, and a long term view. They address efficiency, outcomes, staff impact, and sustainability. They also surface the cost of doing nothing. When leaders understand both sides of that equation, conversations change.

4. Manage long sales cycles with intention

Healthcare sales cycles are long because decisions are shared. Clinical leaders, operators, finance, and often boards all weigh in.

Winning sellers treat the process like a marathon. They maintain momentum through insight and value, not pressure. They cultivate relationships, deliver relevant insight, remain actively engaged, and continue to add value throughout the process.

5. Address resistance to change with respect

Resistance in healthcare is not stubbornness. It is responsibility.

Organizations worry about disruption, safety, and unintended consequences. The fastest way to lose credibility is to dismiss those concerns. The most effective approach shows how change improves care and fits into existing workflows, supported by training and real world examples.

6. Create momentum inside institutional inertia

Large healthcare systems are built for stability, not speed. Change requires internal advocates.

Successful sellers identify champions early and support them with data, insight, and tailored messaging. They map stakeholders carefully and position solutions as necessary improvements tied to strategic goals, not optional enhancements.

7. Prove innovation with evidence

Healthcare does not adopt innovation because it is new. It adopts innovation because it is proven.

Clinical evidence, pilot results, and real world validation are essential. Transparency about risks builds credibility. Aligning innovation with value based care, quality metrics, and regulatory priorities accelerates acceptance.

8. Differentiate through insight, not features

Most healthcare solutions sound the same at a feature level. Differentiation comes from understanding the business of healthcare.

When you bring commercial insight, industry context, and a clear point of view, you stop sounding like a vendor and start sounding like an advisor. Outcomes matter more than capabilities.

9. Earn access to the executive level

Hospital executives care about growth, margin, quality, and risk. They do not have time for tactical detail.

Gaining access requires speaking their language, aligning with strategic priorities, and being concise. Introductions help, but relevance keeps the conversation going. Executives respond to clarity and impact.

10. Sell to physicians by respecting their world

Physicians are focused on patient care, evidence, and time. They are skeptical for good reason.

Effective physician conversations are concise, clinical, and grounded in outcomes. Evidence matters. Positioning yourself as a partner in improving care earns far more traction than a traditional sales pitch.

11. Use data as a strategic asset

Healthcare runs on metrics. Financial, clinical, operational.

Sellers who can translate data into insight stand out immediately. Data tells stories. It clarifies problems. It supports decisions. When you use analytics to help leaders see what is happening and what could happen next, you create value before the sale.

12. Master virtual selling as a permanent reality

Virtual selling is no longer optional in healthcare. It is now the default.

Professional presence, concise messaging, and structured follow up matter more than ever. Virtual meetings reward preparation and clarity. Sellers who treat them casually lose ground quickly.

Healthcare sales mastery is not about persuasion

It is about understanding how hospitals make decisions and helping leaders move forward with confidence. When you align trust, insight, evidence, and execution, sales become a natural outcome of value.

Why Deals Stall and How to Break Decision Paralysis in Healthcare

Most stalled healthcare deals are not lost. They are trapped.

The meetings are constructive. Stakeholders are engaged. The solution makes sense. Yet no decision is made. Weeks turn into months. Momentum quietly dies.

Research highlighted in The JOLT Effect confirms what experienced healthcare sellers already know. Deals stall not because buyers reject the solution, but because they fear making the wrong decision. In complex environments, indecision feels safer than action.

Healthcare amplifies this effect. Decisions carry clinical risk, operational disruption, financial exposure, and reputational consequences. When uncertainty rises, leaders default to delay. They do not say no. They simply stop moving.

Sales teams often misdiagnose this moment. They assume buyers need more information, more proof, or more persuasion. In reality, excess information increases anxiety. Choice overload and unresolved trade offs fuel decision paralysis.

The path forward is not more selling. It is decision enablement.

There are three strategies that consistently help healthcare buyers move out of indecision and into action.

First, reduce the perceived risk of being wrong

According to The JOLT Effect, fear of failure is the single biggest driver of stalled deals. In healthcare, this fear is magnified.

Your role is to make the decision feel safe. That means clearly articulating what happens if the decision works and what happens if it does not. Pilots, phased rollouts, and clearly defined success metrics give leaders protection. When buyers know they can course correct, they are more willing to move forward.

Second, narrow the decision to what actually matters

Stalled deals often suffer from too many variables. Too many stakeholders. Too many evaluation criteria. Too many what if scenarios.

Effective sellers help leaders simplify. They refocus the conversation on the few outcomes that truly matter now. Patient impact. Financial exposure. Strategic alignment. When the decision is narrowed to essentials, confidence increases.

Third, guide the decision instead of pushing the solution

The most powerful insight from The JOLT Effect is that buyers want help deciding, not help buying.

In healthcare, this means stepping into a facilitative role. Clarify trade-offs. Articulate implications. Help leaders weigh options in a structured way. When you guide the decision process itself, movement resumes naturally.

Most stalled deals do not need more selling. They need clearer thinking. Hospitals are complex systems where decisions sit at the intersection of clinical responsibility, financial stewardship, operational reality, and organizational risk. When progress slows, it is rarely because the solution lacks merit. It is because leaders are still working through how the decision fits within that broader system.

Sales mastery in healthcare shows up in this moment. It is the ability to help leaders surface what is unresolved, clarify trade offs, and align stakeholders around a shared understanding of the problem and the path forward. That work is not loud and it is not transactional. It is analytical, facilitative, and grounded in respect for the consequences of the decision.

The most effective sellers know when to stop pitching and start helping. They ask questions that sharpen thinking rather than expand options. They frame decisions in a way that makes risk visible and manageable. They create structure where ambiguity exists and forward motion where complexity has slowed progress.

This is why healthcare sales cannot be reduced to scripts, decks, or tactics. Mastery comes from understanding how hospitals think, how leaders weigh risk, and how decisions actually get made across clinical, financial, and operational lines. When sellers bring that level of clarity to the process, momentum follows naturally.

In the end, the difference between average performance and mastery is not persuasion. It is the ability to help complex organizations move forward with confidence.

If you want to build this level of healthcare sales mastery inside your organization, I lead hands on workshops designed for teams selling into hospitals and health systems. These sessions focus on how hospital decisions are actually made, how to navigate complexity across clinical, financial, and operational stakeholders, and how to create momentum without relying on pressure or tactics. If you are interested in a workshop for your team, reach out to start the conversation at lisa@lisatmiller.com

Schedule a Call

P.S. Need some quick help?
​Browse my ​free resources​ and ​paid program​.

In this podcast, I sat down with Tim Boyle and we had a conversation that opened up several realities about selling into hospitals today. What stood out most was how aligned we were on one central belief. Insight is the differentiator. If you want to sell to hospitals, you need to understand their world at a level most salespeople never reach. You need to think like a consultant, not a rep. You need to know their workflow, their pressures, their blind spots, and the unseen forces shaping their decisions.

As Tim and I talked, we kept circling back to the importance of discovery. Hospitals will give you the familiar surface level objections. We do this internally. We already have a system for that. Our team is fully staffed. These are reflexive answers. The real information only comes out when you know how to ask deeper questions that get inside their operations. I have seen this throughout my career. When you understand workflow instead of reacting to objections, you uncover the real opportunities and the real value you can bring.

Another part of our conversation that resonated with me was the case by case reality of healthcare. There is no universal script. Every hospital, every department, and every leader operates differently. Selling into healthcare requires listening, adapting, and being fully present in the moment. You cannot reuse the same message from one organization to the next. You have to understand frontline work, daily routines, and the constant juggling of clinical and clerical responsibilities. That is where trust is built.

We also talked about workflow knowledge as an essential skill. When I work with hospitals, it is always clear who understands the operations and who does not. Leaders respond differently when they feel seen and understood. During the podcast, I shared a moment when a hospital executive told me it was refreshing to speak with someone who truly understood their day to day operations. That level of understanding is what elevates you from vendor to advisor.

Another important point in my discussion with Tim was the role of relationships in winning large deals. Hospital leadership wants strategic partners. They want someone who thinks like they do. They want someone who brings clarity, financial understanding, and forward looking insights. If you want to land meaningful opportunities, you need to help leaders see the future more clearly than they can on their own.

Finally, we talked about the importance of anticipating trends. Bringing hospitals the information they have not yet considered is one of the most powerful ways to create value. When you turn those patterns into thoughtful commercial insights, you help them think differently about their challenges. This is where true differentiation happens.

Selling to hospitals comes down to understanding, insight, and service. If you want to deepen your impact, strengthen your commercial strategy, and become the person hospital leaders rely on for clarity, schedule a call with me. I would love to help you build an insight driven approach that elevates your conversations and leads to meaningful growth.

Selling to hospitals comes down to understanding, insight, and service. If you want to deepen your impact, strengthen your commercial strategy, and become the person hospital leaders rely on for clarity, schedule a call with me. I would love to help you build an insight driven approach that elevates your conversations and leads to meaningful growth.

Listen to the podcast: How to Sell with Insight in Healthcare

Putting this into Action:

Hospital Cost Improvement Research Report

As I reflected on my conversation with Tim, I kept coming back to something I have believed throughout my entire career. Insight is not just a sales skill, it is an asset you build. It is something you can document, teach, and scale inside your commercial strategy. One of the clearest examples of this is a research report I created several years ago on hospital cost improvement. It became a powerful tool for executives because it organized complex issues, introduced new ways of thinking, and delivered something they could use immediately. I want to share how that report was built so you can see how creating insight-driven content can elevate your position with hospital leaders and open doors long before a sales conversation ever begins.

See The Research Report: Hospital Cost Improvement

How to Build an Insight-Driven Research Report That Sells

A step by step method for turning your expertise into a powerful sales asset

By leveraging insight, knowledge, and genuine value, and by demonstrating expertise, these assets become meaningful sales artifacts. They reshape how people see you, elevate the way they engage with your work, and influence the decisions they make. One of the strongest examples of this approach came from a comprehensive research report I created in 2019. Healthcare leaders found it exceptionally helpful because it blended industry research, internal expertise, and something they could immediately use in their own planning, an Annual Budget Preparation Guide. This structure is powerful because it teaches, equips, and positions you as a thinking partner, not just a service provider. This approach works across industries, regardless of what market you serve or what you sell. Below is the expanded structure, the rationale behind it, and how you can create your own research asset that drives deeper conversations and real commercial opportunities.

Start by grounding the report in a real and timely problem. Every industry has predictable pressure points. When leaders face these moments, they search for clarity and direction. If your report enters the conversation right at that moment, you become the guide they needed. Begin by naming the challenge clearly. Describe the conditions that make this issue significant. When people feel you understand the tension they are navigating, they trust the rest of what you share. This starting point is the difference between content that gets skimmed and content that shapes strategy.

Next, use external research to create altitude. Leaders want context. They want to understand where their challenges fit within broader market patterns. When you reference credible outside sources, you strengthen the weight of your perspective. You also help readers feel less isolated in their challenges. This creates the foundation for insight. You are giving them a clearer map of their world. You do not need pages of data. You only need enough to frame the stakes and define the environment they are operating in.

Once you establish relevance and perspective, introduce a framework that organizes your thinking. Frameworks help people understand complexity in a structured way. They give your ideas staying power. They become the language leaders use internally as they share what they learned. A good framework explains the essential elements of a problem and the pathways to improvement. It is simple enough to remember but strong enough to shape action. When your reader begins repeating your framework in meetings, you have already advanced the commercial conversation without a single sales pitch.

After you share the framework, bring it to life with a practical example. People learn through stories. They believe in methods when they see them applied. Your example should be direct, clear, and related to the exact challenge you opened with. Describe the situation, outline the actions taken, and explain the outcome. This is where you transition from conceptual insight to tangible proof. Readers begin imagining how these ideas apply to their own organization. That moment of recognition is often what creates the desire to work with you.

End your report with something the reader can use immediately. This is where insight becomes operational. When I created the Annual Budget Preparation Guide, leaders used it in real time to make decisions. It moved the report from something they read to something they worked with. Tools like these position you as a partner in execution, not just a source of commentary. They also deepen your credibility because you demonstrate that your expertise translates into practical application. Consider what your audience needs in the next thirty to sixty days, then create a tool that makes that period easier, clearer, or more successful for them.

This approach works because it mirrors how executives make decisions. They want clarity. They want a structured approach to addressing ongoing challenges. They want to see proof. And they want help turning insight into action. When you create a research report with this structure, you shift from vendor to advisor. You become the person who brings perspective, direction, and practical value. This is the foundation of selling through insight. It creates a long tail of influence. People share it internally. They reference it in planning. Your thinking becomes part of their decision making conversations. And when they are ready to take the next step, you are already positioned as the person to lead them.

If you want to develop a commercial insight strategy for your own business, schedule a call with me. Together, we can build the framework, shape the message, and create the research assets that open doors and attract the right executive conversations.

Schedule a call with Lisa

Selling to Hospitals: Additional Resources:

The Ultimate Guide to Life Science Marketing Strategies

Healthcare Sales & Marketing

P.S. Need some quick help?
​Browse my ​free resources​ and ​paid program​.

Thought leadership is more than visibility. It’s about being the one they trust before the conversation starts. In high-stakes sales, the real edge comes from turning your expertise into clear, useful insights that shape your market’s thinking. This edition of Selling to Hospitals shows how to build that kind of relevance, so when a decision comes up for your prospects, your name’s already on the top of their list.

If your reputation precedes you, make sure it precedes you well.

Thought leadership is not optional. In enterprise sales, your first impression is often your first point of disconnect. Why? Because uncertainty feels risky, and risk feels like pain. That’s what people avoid.

That’s where thought leadership comes in. It replaces uncertainty with familiarity. But visibility alone isn’t enough. Awareness might get you noticed. But relevance is what earns your trust.

You don’t want to be just another voice in the feed. You want to be the one who brings clarity to complexity. You want to be that person who speaks directly to what matters most, without noise, fluff, or pretense.

Executives don’t buy from salespeople. They buy from trusted advisors who speak their language, understand the stakes, and help them solve the problems that matter most. When something breaks, when a high-stakes decision is on the line, does your name come up or does someone else’s? That’s positioning. It’s what turns strangers into prospects, and prospects into partnerships.

I didn’t build my reputation by outspending competitors. I couldn’t. I was up against billion-dollar firms, PwC, Deloitte, Navigant. They had sales armies and full-page spreads in trade journals. I didn’t. I focused on what I could control: being more useful, more specific, and more strategic.

Every asset I created had to earn its place. The goal wasn’t brand awareness, it was traction. It was executive relevance. So, I built a body of work around one thing: utility.

Our website, the case studies we featured, every framework we shared, these were all designed for executives in the middle of real decisions. We didn’t fill our site with branding fluff. There was no performance or posturing. We asked ourselves one question: how can we create media that’s genuinely useful? Tools built for serious conversations, not surface-level impressions.

That shift changed everything about how our marketing worked. We stopped trying to convince prospects we were different and instead met them where they were, right in the middle of high-stakes decisions, and led them to the next step. CFOs. CEOs. Quiet leaders with real authority. They didn’t reach out because I was loud. They reached out because I was useful.

“I’d like to book a call.”

That’s the moment you know your content is working. Not because it’s viral. But because it’s trusted. That’s what real thought leadership makes possible. Not just visibility, inbound trust.

You’ve probably heard the phrase, “People do business with those they know, like, and trust.”

In this next section, we’re going to explore the specific strategies that make that trust real. But first, let’s get clear on what thought leadership means. It’s not just content creation or building a personal brand. It’s leverage. It’s what makes your name come up before the meeting is even scheduled. Thought leadership is the strategic act of turning your lived expertise into visible, undeniable proof that you’re relevant, credible, and useful, so when a challenge comes up, you’re already at the top of their list.

Attraction Via Education-Based Marketing

This wasn’t just about showing expertise. It was about structuring that expertise into a useful experience that moved real deals forward.

We had a clear client win, a measurable result with a finance team in a large hospital system. Instead of turning that into a static case study or a branded slide deck, we built a campaign around it that produced multiple six-figure deals. Here’s how we did it:

· Step 1: Start with the Story, Not the Pitch. We recorded a short video that walked through the real numbers. Not high-level jargon. Just a plain, honest breakdown of what we did, how it worked, and what changed. It was sharp, specific, and grounded.

· Step 2: Gate It with Intention. We created a simple email opt-in page to access the video. Just one clean gate to qualify interest and track engagement.

· Step 3: Deliver Directly to Decision-Makers. My team sent the link to carefully selected CFOs and COOs. We didn’t pitch them. We shared the story with a note: “This helped a team just like yours. Thought you might find it useful.”

That campaign brought in multiple high-value opportunities. But not because of the video alone. It worked because it was the right story, delivered the right way, to the right people.

Media ≠ Message ≠ Strategy

This is where a lot of marketers get lost. They think the format is what matters. That a video like this is the magic bullet. But video isn’t the reason it worked.

What mattered was the alignment:

· The strategy was clear: target CFOs who were under pressure to reduce costs and optimize margin.

· The message was sharp: reframe how they thought about underperforming service lines.

· The media was right-sized: a short, watchable video that gave them insight in under five minutes.

We’ve seen the same structure succeed in other formats too. Sometimes it’s a diagnostic tool. Sometimes it’s a benchmark guide or a short, direct-mail letter. You need to use different ways to reach the C-Suite, and typically requires a few ways.

The C-Suite Selling System That Built Trust at Scale

Once we saw this campaign work, we didn’t clone it blindly. We studied why it worked. Then we scaled it with purpose. Here’s the anatomy of that trust-building system:

Lead with Authority and Clarity

We didn’t open with credentials. We led with a sharp question:

“Are you actually making money, or quietly losing it, on this service line?”

That line hit hard because it surfaced a real, often unspoken tension. We framed the problem with clarity and precision, without pitching.

Provide a New Perspective

Instead of listing features, we gave them a new lens.

· We showed them how hidden inefficiencies were bleeding revenue.

· We provided a framework they could use themselves.

· We made them question the way they were looking at the problem.
That’s what creates gravity. That’s what makes executives’ pay attention.

Make the Next Step a No-Brainer

We didn’t immediately ask for a call. We offered:

· A plug-and-play worksheet

· A short benchmark guide

· A limited-time contract review

It was low-friction, high-value. And it moved the problem closer to their desk without asking them to make a commitment. The second they downloaded one of those tools, we weren’t strangers anymore. We were part of their problem-solving process.

What This Actually Teaches You

A lot of people talk about thought leadership. Few define what makes it work. This is it: Thought leadership isn’t about being loud. It’s about being useful. It’s not about building visibility. It’s about building trust, before the first call even happens.

And the way you do that isn’t by picking a trendy medium or pushing out content. You do it by building aligned systems that connect:

· A relevant strategy (who and why)

· A resonant message (what and why now)

· The right media (how and where)

When that’s in place, your marketing doesn’t feel like marketing. It feels like insight. It feels like help. And that’s when executives start reaching out, because they already trust that you get it.

Here’s How You Put It to Work:

These aren’t just exercises. They’re strategic habits designed to help your team speak the language of the executive table, and stay in that conversation once you’re in. Use them to sharpen your presence, improve your prep, and lead with value every time.

Publish Executive-Level Insights on a Regular Cadence. Start producing short, smart content that reflects the priorities executives care about. One-pagers. Strategy briefs. Quick-hit videos. These don’t need to be long, they just need to be sharp. Use them to keep your team equipped and your company top-of-mind when a deal moves from “maybe” to “let’s talk.”

Map Executive Pain Points by Role. Not every executive thinks the same. Create an internal cheat sheet that breaks down what each role in the C-suite prioritizes, from EBITDA sensitivity to operational complexity. This isn’t theory, it’s so your team can walk into the room knowing what keeps that specific executive up at night.

Show Up Where Executives Already Are. Find the industry events, roundtables, and private forums where your target executives gather. Don’t just attend, contribute. Show up consistently, share your point of view, and build reputation by being useful, not promotional. Over time, your name will carry weight before the first meeting even happens.

Train Your Team to Present Like a Peer. Set up live practice sessions where your sales team presents high-level ideas as if they’re speaking directly to the C-suite. No fluff. No filler. Just clean, strategic framing and clear ROI. The goal is to sound like someone they’d bring into a board meeting, not someone they’d hand off to procurement.

Simulate Real Executive Conversations. Create role-play scenarios that mirror real-world executive meetings. Quick pivots. Big stakes. Smart pushback. Get your team comfortable with high-pressure dialogue so they can respond with confidence and clarity, not canned answers.

Build a Ready-to-Go Executive Content Hub. Centralize everything your team needs to walk into executive meetings prepared: case studies, financial impact data, sharp talking points. Make it fast to find, easy to use, and always up to date. Preparation isn’t just about research, it’s about access.

Coach Your Team Like They’re Headed to the Boardroom. Run coaching sessions led by experienced execs or C-suite sales veterans. Use these to level up thinking, not just delivery. This is about helping your team see what executives see, so they can speak to it without guessing.

Create One-Page Visuals That Prove Value Fast. Design short, compelling summaries that make your impact immediately clear. One page. High visual contrast. No jargon. When you drop these in a meeting, they should make the executive pause and say, “Okay, now we’re talking.”

Interview Executives and Share Their Thinking Internally. Talk to execs, yours, your clients’, your partners’. Capture their real-world thinking about strategy, risk, or transformation. Then feed that intel back into your team so they’re always selling with fresh context and real credibility.

Hold an Annual C-Suite Sales Strategy Day. Block the time. Make it a ritual. Once a year, bring your top performers and strategists together to refine how you sell to the C-suite. What’s working? What’s stale? What’s the next evolution of your message, presence, or proof?

Selling to the C-Suite Workshop

If your organization sells into hospitals, the Selling to the C-Suite Workshop delivers an immersive experience that elevates how your team prepares, positions, and communicates with executive buyers.

It combines customized strategy, advanced training, and implementation support, giving your team the skills and insights required to sell effectively in healthcare’s complex environment and to succeed in what will matter most in 2026.

To bring this experiential and result-driven workshop to your company, contact lisa@lisatmiller.com

Schedule a Call on Lisa’s Calendar

P.S. Need some quick help?
​Browse my ​free resources​ and ​paid program​.

There’s nothing more frustrating than getting a meeting with a C-Suite Executive only to have something go wrong. Sometimes you know what that “something” is, and other times you watch things fall apart with little to no understanding about what happened. In both situations, you end up walking away with nothing to show for your time and effort. This is what happens to most companies. It’s not because their product or service is bad, it’s simply because there was a misalignment between the buyer’s problem and the way you presented your solution.

Human beings are wired to pursue what they want. There are very few exceptions to this rule. So if you’re feeling pullback, resistance or it seems like there is confusion, that is a clue. It is a clue that you are not making it clear to your prospective buyer how your product or service can lead them to getting what they want. The bad news is that this prevents more deals than anything else. The good news is that this is largely within your control to change. The secret is to understand the view of the situation from the eyes of your buyer and craft your entire approach to fully align with the goals they want to achieve and their specific definition of “success.”

Whether or not you do this well is what will be revealed during your meeting with the decision-makers. If you are prepared, there’s a good chance your sale will go to the next step. In my experience, the scope of your work can even expand instantly if you perform well with executives empowered to make real decisions.

Reframing the Purpose of the Meeting

One of the biggest mistakes companies make when selling to healthcare is to develop “tunnel vision.” This is when all they can see are the priorities they have for themselves instead of navigating from the perspective of the buyer.

Remember THIS - selling to healthcare is not about you, your goals, your projections, your desire to achieve real success. Selling to healthcare is about serving your buyer in a way that no one else can. That’s why you will get the sale. Because you made a case and demonstrated why choosing you would provide a benefit to the buyer they cannot get from any other source. It’s about them.

What does this shift in perspective mean when it comes to preparing for a successful meeting with your prospective buyer? It means that the entire purpose of the interaction has completely shifted. Most companies get the meeting to sell their products and services. Selling to healthcare requires a different approach.

The purpose of the meeting is not to pitch. The purpose of the meeting is to solve. To show that your company can solve the real problems of the buyer. No buyer in any company in healthcare wakes up in the morning and asks to spend the day listening to sales presentations. They are looking for solutions to problems. That’s what they want.

That’s what your presentation needs to be about. Yes, you are creating trust. Yes, you are talking about your product or service. But all of those create the support structure for your true goal, which is to prove that you know how to solve the problems that are keeping your prospective customer from getting where he wants to go.

This perspective shift serves as a pressure valve for the person doing the presenting. You’re not showing up in front of executives to do a “song and dance” and hope they like it. You’re showing up to demonstrate an authentic desire to serve and to show that you understand how to move the organization forward towards its goals in a way that no one else can.

Creating an Advantage No One Can Duplicate

Success does not happen by chance. It is the result of preparation. Most companies selling to healthcare treat the sales presentation as a rather static event. They have information they need to convey to the prospective buyer, and the presentation will do much of the “heavy lifting” to move that buyer towards the sale. It will communicate the primary features and benefits of the product or service and explain exactly how it will add value to the buyer’s organization.

This might be a valid strategy selling to small businesses, but at this level, inside of large organizations, with large deals hanging in the balance, the bar for success is much higher. If you walk in and offer a presentation like most companies I’ve witnessed over my decades in healthcare, you will blend in with all of the other “noise.” The chances are good you will never hear from your prospective buyer again. Communication will go dark. You will be forced to “follow-up” and “check-in” until you decide to quit.

The success of your sales presentation is not actually determined by the presentation alone, it is determined by the quality of the preparation that goes into creating the presentation. Preparation, done well, done strategically, will lead to a sales presentation unlike anything your buyer has probably seen before. It will instantly set you apart from the long list of “features and benefits” slide decks that put buyers to sleep.

The sales presentation is not about you. It is not about your company. It is not about making a strong argument for how great your product or service is, how capable, agile or experienced your team is, or anything else about you. The sales presentation is about your buyer. It is about their needs. It is about their dreams. It is about showing them that your product or service can serve as the vehicle to move them towards their goals.

This understanding leads to a completely different approach to building a sales presentation that will create impact. When your goals are aligned with the goals of your prospective buyer, everything will change.

Laying the Foundation For the Sale

When you understand that the purpose of the sales presentation is to demonstrate you know how to solve the problems of your buyer, everything changes about the focus of your preparation.

The spotlight shifts from you and your company to the buyer and his problems. Before we get into the details of how and what to prepare for your meeting, understand that the foundation for a successful outcome is built on your understanding of the product or service you sell.

The knowledge and understanding you have of your product or service is not something you relay directly to the buyer. It serves as the raw material from which you draw to create the insights, perspectives and recommendations that will set you apart from everyone else competing for the sale.

Digging For Gold

This is the point in the process where you become a consultant to your buyer. Even if you’re selling. Even if getting the sale is your entire goal. This not only gives you a real advantage of substance with your buyer, but it also completely shifts your position in relation to the buyer and the other companies competing for their business. Instead of sitting across the table from your buyer, you end up sitting on the same side of the table as they are, seeing the world from their perspective.

A consultant understands the position of the buyer in an objective way. To develop this level of understanding, a consultant spends a fair amount of time gathering the information and other data required to firmly grasp how the organization functions and where the obstacles are that are limiting success.

A consultant can propose solutions to problems that are known and also highlight problems that others do not see. If you want to truly stand out to your buyer, identify serious problems they were not aware of and show how your product or service can solve those in addition to their core challenges.

The smart strategy is to go “digging for gold.” This means you are collecting the necessary data and information to see what others do not. You start by deepening your understanding of the problems your buyer is experiencing. This transforms the quality of your research and gives it a focused purpose. You are looking for things you might not have been told. You are looking for insights about how the organization is functioning, the obstacles it is experiencing and possible solutions for removing those obstacles. You can use publicly available information like earnings calls, press releases, or interviews to achieve this.

In the book The Challenger Sale, they call it “Commercial Insights.”

Commercial insights are the backbone of what makes a Challenger rep stand apart. Instead of echoing what buyers already know or chasing surface level needs, commercial insights reframe the customer’s reality. They reveal a problem, cost, or missed opportunity the buyer has not fully recognized, and they connect that insight directly to the unique strengths of the seller’s solution. The power of a commercial insight is that it disrupts the buyer’s current thinking in a way that is both surprising and undeniably relevant. It teaches the buyer something important about their business and creates constructive tension that pulls them toward change. When done well, commercial insights shift the conversation from price and features to value and impact, positioning the seller not as a vendor but as the only partner who truly understands what’s at stake and how to solve it.

Understand that this is the real work when it comes to selling to healthcare. Giving the presentation is not the work. That’s the byproduct of the work. From the C-Suite perspective, executives value meetings that are tightly organized and purpose-driven. They often have limited time, so every interaction needs to demonstrate value quickly. You can’t do that if all you know about is your product or service.

C-Suite executives appreciate when salespeople come prepared with a strong understanding of their specific challenges. This is why pre-meeting preparation is so crucial.

Structuring a Presentation They Won’t Forget

I have sat through countless bad presentations to healthcare executives. Presentations that had no purpose, no energy, no focus. Presentations that didn’t “solve,” only pitched. Presentations that were a conclusive demonstration that a seller had little to no understanding of the real problems their buyers were facing. If you want to create endless frustration when selling to healthcare, destroying all of your hard work with a single bad presentation is the way most companies do it.

Bad presentations make great potential buyers run away. They can tell, almost immediately, that you are not ready to perform at the level they require of a solution provider. That’s why they go silent after the meeting. That’s why they don’t respond to your follow-up, that’s why you can never really get an answer, often until months later, about the decision they made. You got the meeting because someone thought you might be a good choice. Your presentation proved to the executives that that you aren’t.

What makes a “bad” presentation?

• Buzzwords without substance ruin a presentation. The more jargon you use, the further you move from addressing your buyer’s challenges.

• Overly technical details also ruin a presentation. Unless your buyer specifically asks for a presentation like this, keep the technical information to a minimum. Even if your product or service is technical, it is simply serving as the vehicle to move your buyer towards his goals. The more tightly your presentation remains focused around that purpose, the better it will perform.

• Overpromising is another activity that will poison your presentation and sabotage your relationship with your buyer. As one CEO mentioned to me in my interviews, “Nothing kills trust faster than saying you can do everything when it’s clear you can’t.”

Based on my experience, here is the presentation framework preferred by C-Suite executives:

• Open with their priorities: Start by summarizing their known challenges or goals. You want to show them, right from the beginning, that you’ve “done your homework.”

• Focus on outcomes: They don’t want to hear what you do, they want to know what they will get. Make the presentation about their results, not just your product or service.

• Keep it visual and concise: Executives prefer clear, impactful visuals over dense slides of text. You get no awards for the volume of information you provide, you only win if it becomes clear to your buyer that you can solve their problems in a way no one else can.

• Allow for interaction: They value conversations over monologues, so design your presentation to invite discussion.

The most important thing is to never lose sight of your strategic focus for the presentation. This will set you apart from every other choice you buyer has in a way that nothing else can. The strategy is simple: the goal of the presentation isn’t always to “close the deal” but to build alignment and set the foundation for a partnership. You are not just pitching a solution, you are co-creating one in cooperation with your buyer.

This means that the real goal is often trust-building. As one CFO I spoke with explained, “We’re looking for people who understand our world and can make our lives easier.”

To do this, you want to make sure that your presentation includes these important ingredients:

• Proof of credibility: Success stories and/or metrics can provide proof that your solutions create results. As always, make sure you keep them relevant to the problems your buyer wants to solve.

• Unique insights: Your goal is not to “please” them. Your goal is to lead them somewhere they aren’t able to get on their own. Executives don’t want generic ideas—they want you to challenge their thinking and address their specific problems.

• Practical next steps: End your presentation with a clear, actionable roadmap that your buyer can easily align with. You know where they want to go. Show them how to make it possible. Layout what that journey can look like.

Your presentation should position you as someone who can guide your buyer towards the goals they want to achieve. If you act like a seller, you will be treated like one. If you act like an advisor and demonstrate that you are worthy of trust, you will be given access to a level of respect and attention few “salespeople” will ever see. The secret is to put your focus on the long-term success of your buyer. That’s a strategy that will set you apart from almost everyone.

What Comes After the Meeting

Selling to healthcare is part art and part science. It is a combination of strategy and street-smart intuition that you develop by truly understanding your buyer’s situation. Strategic preparation is an important part of this recipe, but understanding how to “read the room” is extremely important too.

C-Suite executives prefer meetings that end with clear next steps. You don’t want to leave them wondering what is supposed to happen. You are assuming the role of trusted advisor, so that means that guiding your buyer to what’s next is an important function you provide.

End your meeting by recapping key takeaways, clarifying any agreed-upon actions and setting expectations for follow-up. This is the plan. This is also the part of the process where the “street-smart intuition” is important. You must be prepared to read the room. Some executives might want to dictate next steps, others might expect you to take the lead.

How to Follow-Up

C-Suite executives appreciate thoughtful follow-up. Most companies have no idea what this looks like, how to do it or how to elevate this activity to a form of marketing that can increase attraction, strengthen differentiation and make traditional “selling” completely irrelevant.

Here is my “Golden Rule of Follow-Up,” which states: every interaction with your buyer must add value in some way. The important part isn’t to say this rule, it’s to understand what it means so you can put it into practice.

Emails or phone calls to “check-in,” “follow-up” or “see how things are going” break this rule. They add zero value to a C-Suite Executive. If you remember nothing else, remember never to create one of these communications. They push your buyer away by transforming you into a pest.

After you meeting, this is what works:

• Send a summary within 24 hours: Highlight what was discussed, agreed upon, and next steps. Make it concise, make it clear. This serves as a reminder that your entire presentation focused on the needs of your buyer.

• Deliver any promised materials: Whether it’s a case study, proposal, or other data, send it promptly. Trust is created by promises being made and promises being kept. Even the smallest promise made is an opportunity to strengthen the trust your buyer has in you and your company.

• Stay visible: Executives appreciate periodic updates or insights that keep the conversation going without being pushy. This is where adding value becomes a necessity. How can you move your buyer forward towards solutions even before the sale is completed? That’s the question to constantly ask yourself.

• Offer a proof-of-concept project. Putting real “skin in the game” is not the traditional behavior of salespeople. This is why you should do it. Not only will a proof-of-concept project allow you to demonstrate the quality and effectiveness of your proposed solution, but your willingness to go “above and beyond” in a way that adds real value to your buyer will instantly separate you from the crowd.

The real secret is to make every interaction with your potential buyer one that adds value. This strategy creates “empathy in action.” It shows you understand your buyer instead of just saying you do.

Selling to the C-Suite Workshop

If your organization sells into hospitals, the Selling to the C-Suite Workshop delivers an immersive experience that elevates how your team prepares, positions, and communicates with executive buyers.

It combines customized strategy, advanced training, and implementation support, giving your team the skills and insights required to sell effectively in healthcare’s complex environment and to succeed in what will matter most in 2026.

To bring this experiential and result-driven workshop to your company, contact lisa@lisatmiller.com

Schedule a Call on Lisa’s Calendar

P.S. Need some quick help?
​Browse my ​free resources​ and ​paid program​.

Selling into hospitals today requires more than persistence or a clever outreach sequence. Executives are overloaded, protective of their time, and quick to dismiss anything that feels generic or transactional. Teams that don’t have a clear executive strategy often burn cycles chasing access without ever creating the kind of conversations that actually move a deal forward.

While getting in the door can be a challenge, that’s just the beginning. If you don’t know what to do when you get there, you’ll end up frustrated, confused and probably resort to the same old ineffective methods that other companies are using to sell to healthcare.

The C-Suite Stack is the solution. Understanding the core components and putting them into practice in your company will complete transform how you show up in front of prospective customers.

There are three parts to the C-Suite Stack. They are: Be Valuable, Be Different, Be Discovered. Notice the one obvious thing that is not included in this three-part approach? Selling your products and services is not included here in our list of priorities. Is that a mistake? Shouldn’t we always be trying to sell what we have to qualified buyers?

Of course. The question is “when should you be doing this and how?” That’s what the C-Suite Stack is about. This is not a todo list that you execute, it’s not a process you move through step by step. This is a way of being that will completely shift the results you create in your company. The C-Suite Stack will lead to members of the C-Suite buying what you have, buying more of what you have and buying it more easily than ever before.

The C-Suite Stack is not a tactic for selling, it is a completely counterintuitive strategy for making sales happen as a byproduct of achieving things that are important to your buyer. At this point in our journey, these two paths might sound very much like the same thing. But I assure you, as we move through, it will become clear to you just how different they are from each other. The perspective of traditional selling is to get your product or service in the hands of the buyer. The perspective you take in the world of C-Suite Selling and in the implementation of the C-Suite Stack is “how can I solve my customer’s problems better than any of their other options?”

THE C-SUITE STACK PART 1:

BE VALUABLE

If you ask a C-Suite healthcare executive about whether or not companies trying to sell to them make their life better or worse, what do you think they would say? Would they even know how to answer that question?

Are all of the companies trying to get the attention of executives in the C-Suite adding value to the lives of those executives or removing it? Imagine yourself on the receiving end of the calls, the emails, the “follow-up,” the never ending “check-ins.” At what point would you look out at the crowd of companies trying to sell to you and label them as little more than annoying pests? It probably wouldn’t take long.

To make more sales, you don’t need fancy ways to “get the meeting,” you learn how to transform the way you approach selling so that you become worthy of making more sales more easy. Remember, the sale is not the goal, it is the byproduct of the goal. The real goal is progress for your buyer: moving them forward towards their goals and improving their life in some clear and powerful way. When you can make it clear to your prospective customers that their life will be better with your solution, when they truly understand that, and believe it, making the sale becomes pretty simple.

Digging Deep to Find the Connections

The first thing I do when a new sales opportunity appears on my horizon isn’t to work on a sales presentation. The first thing I do is start studying and doing research. A lot of research. It might sound odd to most people in selling that research is one of the most powerful competitive advantages you can have, but it is. Understanding your buyer’s problems as well as you understand your products and services will give you an enormous competitive advantage that you can see in real dollars and cents. You will sell more, sell more easily, sell more often if you do this right.

What am I researching?

Most people in sales take a very shallow approach to communicating about their product or service. Most have a long list of features and benefits. And they are ready to counter “objections.” They might even be prepared with some fancy marketing collateral that supports the main ideas of their presentation. If you want to win million-dollar deals, even against billion-dollar companies, you do not want to act like these people.

In a traditional selling situation, the seller is communicating the value of the product or service to the buyer. The event is largely a transfer of information from the seller to the buyer. The buyer is then left to make a choice about the right way forward.

This is the approach that makes selling hard. You want one thing to happen, and you try everything you can to get the buyer to want it to. With this approach to selling, you will struggle. You will work very hard for what will most likely be very little. Why? Because you have not aligned what you want with what your buyer wants. And because of that, you sit on opposite sides of the table. You’re trying to make a sale and the buyer is trying to figure out if buying is a smart idea.

The answer to this problem is to go deeper with the way you approach selling. Does the traditional approach to selling make you valuable to the buyer? Not usually. And that’s the problem. The more valuable you can become, the more effortless the sale will be.

Value is a byproduct of understanding. It is the result of insight. It is created when you bring something more to the table than what is obvious. Anyone can tell a prospect about the features and benefits of a product. Fewer people truly understand the real problems of a buyer and have the ability to show how those problems can be solved in new and innovative ways. Very few people in the world of selling realize that their ability to add deep insight about helping their clients and customers move towards their goals is how you make the need to “sell” completely irrelevant. If someone approached you with a solution that could solve the biggest problems in your life, something that they showed you could solve problems you didn’t even know you had, and you saw that what they said was true, wouldn’t you be interested in hearing more?

What does “adding deep insight” mean? It means that you, as the seller, as a solver of problems, have the understanding of the buyer’s condition required to not only solve the problems they have but to completely redefine how they view those problems. Your goal is to help them better understand their problems and see solutions where before they only saw obstacles.

The raw materials required for making this happen come from research. It’s the research that allows you to make the deep connections required to deliver insight. One of the important components of the C-Suite Stack is redefining your role from traditional salesperson to what is really a business consultant who happens to sell a particular product or service. If you can think like a consultant would think, the sale will become a natural byproduct of that approach.

Imagine walking into a sales opportunity with four other companies using the traditional approach to selling. After they are done presenting, you arrive and show the prospective buyer how his company can use your product or service to solve the multi-million-dollar problem no one even told him he had. Who do you think is going to get the sale?

THE C-SUITE STACK PART 2:

BE DIFFERENT

The human mind is trained to sift and sort very quickly. If it sees something that is too different, chances are good that thing will be labelled as a possible threat and met with resistance. If the mind sees something it can classify as a “known entity,” something it has seen before, it will stop its analysis of the thing and move on to something else.

If you show up like everyone else, you will be invisible. You will be grouped in with all of the other vendors and dealt with just as they are. This is the experience of most companies when they attempt to sell what they have in the world of healthcare. They are generally treated like pests.

The goal isn’t to be different in your tactics, although that probably won’t hurt. The goal is to be different at such a deep level, that you become impossible to copy or emulate.

What does it take to be different?

The Anatomy of Difference

The consulting firm I founded was focused on helping hospitals reduce non-labor costs. Like most consulting firms, we had benchmarking data, analytics, subject matter expertise and implementation. Had that been everything we offered, it would have been a hard road.

But we were different. Different in perspective and different in result. When I started, it was about aligning what I was offering with goals, outcomes and results. A lot of companies say that, but far fewer can SHOW it. What’s the ROI? Do you know? Can you show it? Can you prove it?

We demonstrated our commitment to results by going to the extreme in how we structured our compensation. Our pay was based on our performance. If we didn’t reduce non-labor costs, we didn’t get paid. Over time, we started mixing fee-based arrangements with savings-based arrangements as our reputation in the marketplace began to grow. But we started by putting “skin in the game” and showing our prospective buyers we were serious about generating measurable results.

I knew back then that you wouldn’t be able to beat a company who was willing to get paid on performance. We made it obvious that our success was contingent upon the success we helped our customers achieve.

On the journey to be “different,” it’s important to remember that any differentiation has limited value if it is something that can easily be copied by others. While most companies don’t want to get paid on performance, it wasn’t something that was too difficult to copy. So we needed something more, something that would truly set us apart from every other company in the space.

Developing the Ultimate Solution

Do you offer the “ultimate solution” in your market? Is the solution you offer more valuable, by an order of magnitude, than any other choice your customer has? When I founded my company, our answer to that question was no. We had drive, we had focus, we had experience and a strong desire to help our customers get measurable results. What we didn’t have, yet, was a product or service that so completely solved the problems of our customers that choosing any other option would be an obvious mistake.

As you know, the inner workings of a healthcare organization are extremely complicated. That complexity requires focus. And while focus is good, it can make you blind to seeing solutions across broader parts of the organization. It didn’t take us long to start discovering major obstacles that were keeping our customers from achieving their goals. Our desire to dig deep into the various parts of our customer’s organization meant we could see things that weren’t working even if they were outside of our customer’s immediate field of vision. The difficult part was creating the solution required to remove these obstacles.

For us, this solution came in the form of technology. We created software that would search through all of the electronic and paper invoices coming in from a long list of vendors and capture all of the data required to make getting analytics at scale possible. This solution was so unique, so valuable, we were awarded a patent for its creation.

From the perspective of our customers, this technology was a miracle. It was the “Ultimate Solution” to a problem they knew they had but were never truly able to understand because of the complicated way the data was flowing through the organization. This technology wasn’t created because we had access to the best computer scientists on the planet, it was created simply because we understood the problem we needed to solve for our customers to get them results they could not ignore.

What many companies don’t understand is just how valuable they could be. You don’t have to be a genius or even get lucky. What is required is a desire to deliver results to the customer that is so strong, you are propelled to do the work that everyone else in your market is not willing to do. Sometimes this work comes in the form of manual labor. This was our path as we worked through how to transform analog data from paper invoices into immediately actionable intelligence across an entire organization. Sometimes this work comes in the form of seeing differently, or at the level of strategy. Every market is different. Every company is different. But if you want to create bigger results in selling, this is where your focus should be.

Even now, your organization has a unique collection of people, processes, insights and solutions that can solve problems for your customers. How do you leverage that collection of assets so fully that no one else in your space even comes close to the measurable value you can provide? How can you solve your customers’ problems better than any other choice they have?

As you begin thinking about how to be truly different, remember that incremental difference is a race to the bottom. “We can do it faster,” or “we can do it cheaper” is a direction that leads to everyone losing. Be the company in your marketplace that can solve problems for your customer in a way that no one else ever considered to be possible. What would that take? What would that look like? How could you deliver THAT? Engaging in that type of thinking is where you will find the clues to create the Ultimate Solution you provide to your customers. If you want to be truly different, the difference must be real.

THE C-SUITE STACK PART 3:

BE DISCOVERED

A good question to ask yourself, is, “when does the sale begin?” Some people might say it begins with that first outgoing call or email to your prospective buyer. Others might say it really doesn’t begin until that first meeting where you get to present what you have. In the world of C-Suite Selling, in the world of people winning million-dollar deals against billion-dollar companies, the sale begins long before either of those two events. In fact, the sale begins before you even know who your future customer is.

Imagine these two very different sales scenarios: In the first scenario, you’re searching on the internet for information about solving a particularly difficult problem in your company. You begin reading material published by several experts who focus on solving your exact problem. As you review your findings, you realize that, among the available experts focusing on this issue, one of them really stands out. Without even meeting this person, you realize they have an excellent understand of the problem you are facing. You reach out to setup an initial meeting to explore how this expert could solve your problem in an effective way.

In the second scenario, we are dealing with the exact same situation. You are experiencing the very same problem in your company as before. The expert is exactly the same as well, with the same experience level, same skillset, same performance ability, same track record. The only difference with this scenario is that, instead of you searching and finding the expert, the expert finds you by sending a cold email to your inbox asking for a meeting. And then they follow-up with four calls over the next two weeks.

Which scenario do you think is more likely to lead to a sale? The answer is obvious. If you enter the world of your prospective customer like every other vendor, via what is little more than interruption, you will struggle compared to the company who receives a direct invitation to appear in front of the C-Suite to present what you have. This is a simple way to illustrate a very important and powerful point: everything in selling is easier when it begins by discovery.

The good news is that “discovery” is not an event that happens by chance, it is an event that you engineer, strategically, on purpose.

How to Engineer Discovery

If you want to create sales results that are superior to most companies, you have to use a strategy and action plan that are different. This is not an approach where you develop a better way of dealing with obstacles to the sale, it is an approach where your overall strategy makes those obstacles disappear. For example, most companies will focus on getting past the gatekeeper. You will focus on never having to confront a gatekeeper. This method is not harder, it is just different.

Research shows that 60% of the C-Suite conducts more than 6 internet searches per day, looking for solutions to their problems and new ideas on how to run their operations. What this means is that “being discovered” is easier than ever. But very few companies understand the power of preparing the foundation for sales in this way.

If you look at a lot of the companies selling to healthcare, you don’t find much helpful information, readily available to the public, that would make the decision to choose them simple. Sometimes it’s even hard to find a real human behind the corporate façade built to create a certain perception in the marketplace. Other times, there is a face, a real personality, representing the company, but that individual doesn’t offer much of substance that would attract attention.

What unique perspectives do you bring to the conversation about the problems you solve for customers and how your products or services do that in a better, more effective way? Have you made those clear to the world, in advance of any sales opportunity? This is a conversation that is far beyond the typical “marketing speak” of features and benefits. You can get all of those in a single, boring, presentation slide.

What you rarely find on such a slide is the demonstration of the solution to a customer’s problem that is so clear and compelling that it creates an immediate response of “we need that” in the mind of the buyer. To get that type of a response, you need to take a position. You need to stand for something real that the customer cares about. You need to have an opinion on the way you solve problems for your customers that makes sense, that’s different, that leads to real results.

Once you have that perspective, the goal is to get that communicated before you even meet the customer. Ideally, you want them to discover it and then reach out to you.

It does not matter if you are a CEO or have a job in sales, to be successful selling to healthcare in the C-Suite, you want to be discovered. You want to be invited in. You want to be looked to as the obvious expert in your field. The way you achieve that position is to be worthy of achieving it.

When I was building my company, most of our competitors didn’t understand the power of discovery. They maybe had one research report and one video about their work available for prospects to review. At my company, I had about 200 videos and 30 research reports. We published these so that we could get our ideas and perspectives in front of prospective buyers and have them realize we were completely unlike any of their other choices. To say it worked would be quite an understatement.

These reports and videos, simple but powerful pieces of content, got “found” by CFO’s, CIO’s, and COO’s who then requested a call that led to us landing seven-figure contracts in the C-Suite. This is the true power of the C-Suite Stack.

Content Vs. Value

There is a big difference between creating content and creating value with content. So much of the “content” you see online from companies selling to healthcare will put you to sleep. There’s no point of view. There’s no position being taken. There’s no clear argument being made to guide the reader or viewer to solve their problems.

If you’re looking to “be discovered” and earn the attention of the C-Suite, the number one rule is this: don’t say things everyone already knows. If you publish content like that, content that doesn’t add anything unique and valuable to the conversation, you will be invisible.

If you want to be discovered, you need to say things in your publications that others are not saying. When I was building my company, I created podcasts and videos about trends I was seeing. I added a layer of perspective and opinion on top of what was happening. That is how you create value from nothing.

Because we were so involved in the work and had a deep understanding of the problems facing our customers, everything we published rang true. It allowed us to see patterns and connections that most everyone missed because they were focused on selling instead of serving. Their goal was getting the product or service into the hands of the buyer, not solving the buyer’s real problems.

Even today, with AI and the ability to create “content” with a single keystroke, the bar is very low when it comes to publishing high-quality material. Content is not about transferring information, it is about delivering insight, understanding and real value.

If you want to be strategic about your selling and put yourself in a very unique and powerful position in the marketplace, create the “body of work” required to be discovered. It is effort that will produce a return for months and even years. As I was preparing for the sale of my company, I stopped creating new content online. Four years later, that content still shows up number one in our main category. It is work worth doing.

If you want to take these ideas further and apply them directly to how your team sells into hospitals, there is a structured way to do it. The Selling to the C-Suite Workshop brings these principles to life in an immersive format built specifically for complex healthcare selling.

Moving a sales organization from a product-led approach to an executive-level, outcomes-driven approach is one of the most valuable transformations a company can make. In a product-led model, sellers focus on features, functions, and isolated problem-solving, which often limits conversations to middle management and commoditizes the solution.

By contrast, elevating to the C-suite and Executive-Suite means reframing those same capabilities in terms of organizational outcomes, strategic vision, and measurable business impact. Sellers learn to connect not only to the company’s top priorities, growth, cost efficiency, risk reduction, but also to the personal goals of executives who must deliver those outcomes. This shift creates meaningful differentiation, shortens sales cycles, and increases deal size, because decisions at the executive level are driven by strategy, vision, outcomes and return on investment, not feature comparisons.

The value of making this transition is transformational, as it changes the sales conversation from “why this product” to “how this solution can transform my business, how it can deliver the outcomes I need, and how it can accelerate results.” This shift gains executive sponsorship, enabling your team to win deals ahead of the competition.

If your organization sells into hospitals, the Selling to the C-Suite Workshop delivers an immersive experience that elevates how your team prepares, positions, and communicates with executive buyers.

It combines customized strategy, advanced training, and implementation support, giving your team the skills and insights required to sell effectively in healthcare’s complex environment and to succeed in what will matter most in 2026.

To bring this workshop to your company or next sales meeting, contact lisa@lisatmiller.com

Schedule a Call on Lisa's Calendar

P.S. Need some quick help?
​Browse my ​free resources​ and ​paid program​.